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resumo 
 
 
A prevalência de bactérias resistentes a antibióticos em ambiente hospitalar 
tem vindo a tornar-se dramática e preocupante a nível mundial. Contudo, com 
a utilização inadequada de antibióticos em áreas tão diversas como a 
veterinária, a aquacultura e a agricultura, esta deixou de estar confinada ao 
ambiente hospitalar, sendo o ambiente um reservatório natural de 
microganismos resistentes a estes compostos. 
O conhecimento detalhado dos determinantes de resistência a antibióticos 
presentes nestes ambientes, sejam estes genes de resistência ou estruturas 
envolvidas na sua mobilização, é fundamental, não só do ponto de vista do 
conhecimento como para a eventual implementação de medidas de contenção 
da sua disseminação. Neste contexto, são necessários estudos que permitam 
conhecer o panorama mais realista da distribuição destes determinantes de 
resistência a antibióticos, quer no meio ambiente quer no ambiente clínico.  
Assim, constituiu objectivo principal deste trabalho contribuir para o 
conhecimento do panorama actual da prevalência e distribuição dos elementos 
ISCR, bem como de outros determinantes de resistência a antibióticos em 
espécies de Gram-negativo clinicamente relevantes (Escherichia coli, 
Klebsiella pneumoniae, Acinetobacter baumannii e Citrobacter freundii) 
recolhidas a partir de amostras de pacientes do Hospital Infante D. Pedro, 
EPE, Aveiro, Portugal, entre 2006 e 2008. Adicionalmente, foram também 
recolhidas bactérias de Gram-negativo do meio ambiente, a partir de amostras 
de águas e de vísceras de peixes, nas quais foram igualmente pesquisados os 
elementos acima referidos. À excepção dos isolados de E. coli e de Gram-
negativo ambientais, todas as estirpes estudadas foram seleccionadas com 
base no seu perfil de multirresistência a antibióticos.  
Os resultados mostraram que em todas as espécies recolhidas no ambiente 
hospitalar foi detectada a presença de elementos ISCR, do tipo ISCR1 ou 
ISCR2. O elemento ISCR1, foi encontrado em isolados de E. coli, K. 
pneumoniae e C. freundii e o elemento ISCR2 em isolados de A. baumannii. 
Não foi detectada a presença de ISCRs nos isolados de Gram-negativo 
ambientais, o que sugere que a ocorrência dos mesmos é fortemente 
influenciada pela pressão selectiva exercida pelo ambiente em que os 
microrganismos se encontram. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genes qnr e integrões de classe 1 foram os determinantes de resistência 
mais frequentemente encontrados associados aos elementos ISCR1. Os 
vários determinantes de resistência foram encontrados em diferentes 
contextos genéticos e localizados em estruturas móveis, nomeadamente em 
plasmídeos.  
O elemento ISCR2 presente em isolados de A. baumannii encontra-se 
associado ao gene sul2 em todos os isolados, dentro de um mesmo contexto 
genético e com uma localização cromossomal. Contudo, o contexto genético 
encontrado nestes isolados é novo não tendo sido descrito até à data em 
outros microrganismos.  
O presente estudo constitui a primeira descrição de elementos ISCR 
intrinsecamente ligados a genes de resistência a antibióticos, em Portugal. 
Uma vez que estes elementos parecem ser responsáveis pela mobilização de 
um grande número de genes de resistência a antibióticos, a sua elevada 
incidência entre estirpes resistentes e multirresistentes, bem como a sua 
associação com genes de resistência é preocupante e requer vigilância. 
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abstract 
 
Within the hospital environment, antibiotic resistant bacteria are a problem of 
concern worldwide. However, the antibiotic resistance has breached outside 
the confined hospital environment due to an inappropriate and intensive use of 
antibiotics in areas such as veterinary, aquaculture and agriculture, being the 
natural environment also a reservoir of antibiotic resistant microorganisms. 
Accurate and detailed studies focusing on the existing resistance determinants, 
either resistance genes or structures enhancing/involved in their dissemination, 
is needed in order to provide a realistic scenario of their distribution as well as 
for the implementation of measures that could prevent the dissemination of 
those genes. Thus, studies giving a wider and realistic panorama of the 
distribution of antibiotic resistance genes in both the natural and the hospital 
environment are of utmost importance.  
The main goal of this thesis was to contribute to the present knowledge of 
distribution and prevalence of antibiotic resistance genes and ISCRs elements 
in clinically relevant Gram-negative species (Escherichia coli, Klebsiella 
pneumoniae, Acinetobacter baumannii and Citrobacter freundii) collected from 
clinical specimens from patients in the Hospital Infante D. Pedro, EPE, Aveiro, 
Portugal between 2006 and 2008. Additionally, environmental Gram-negative 
isolates, collected from water and fish guts were also screened for the 
presence of the ISCR elements. All the isolates that were included in the 
present study were multi-drug resistant, with the exception of Escherichia coli 
and the Gram-negative environmental isolates. 
The results obtained revealed that the ISCR1 and ISCR2 elements were 
present in all the species collected within the hospital settings. ISCR1 was 
present in E. coli, K. pneumoniae and C. freundii isolates and ISCR2 was 
detected in the A. baumannii isolates. The presence of ISCRs was not detected 
among the environmental Gram-negative isolates, suggesting that the 
occurrence of ISCR is clearly biased by the pressure exerted by the 
environment from where the microorganisms were isolated. qnr genes and 
class 1 integrons were the main resistance determinants found associated with 
ISCR1 and were both described in different genetic contexts, located on mobile 
structures such as plasmids. Moreover, the ISCR2 element was found 
associated with the sul2 gene in all the A. baumannii isolates with the same 
genetic context and located on the chromosome. Noteworthy is that the genetic 
context described is unique and was never described before in other 
microorganisms. This is the first study reporting the presence of ISCR elements 
in Portuguese isolates. Since these elements are responsible for the 
mobilization of several antibiotic resistance genes and were found intrinsically 
linked to them, their high incidence, among multi-drug resistant isolates is 
disconcerting and requires surveillance.  
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1. Introduction 
 
In the beginning of the last century, several pharmaceutical companies 
made substantial efforts on the research and development of new antibiotics 
(Alekshun and Levy 2007). The current era of antimicrobial chemotherapy began 
in 1935, with the discovery of sulphonamides. Later in 1940, it was demonstrated 
that penicillin could be an effective therapeutic substance. Since the introduction of 
penicillin in the 1940s, many antibiotics have been approved and launched into the 
market. Their availability transformed clinical practice, in a way where bacterial 
infections that were the scourge of humanity for so long, have until recently been 
overlooked, rather than being considered as life-threatening conditions (Bennett 
2008; Hawkey 2008). Nonetheless, the discovery and development of a multitude 
of antibiotics have undoubtedly contributed to a decrease in human mortality 
associated with bacterial infections prior to the “antibiotic era” (Bennett 2008; 
Harbottle et al. 2006). Although Alexander Fleming selected and described 
mutants resistant to penicillin soon after he discovered the antibiotic, thereby 
foreseeing resistance to antibiotics, no one could predict how quickly bacteria 
would acquire the capacity to deal with multiple antibacterial agents (Alekshun and 
Levy 2007; Harbottle et al. 2006; Hawkey 2008).  Indeed, bacteria exhibited 
different mechanisms of resistance, immediately after antibacterial drugs were 
deployed (Tenover 2006). Strains of Shigella bearing self-replicating and self-
transferrable plasmids were easily selected and propagated during a period of 
considerable sulfonamide use in Japan after World War II (Watanabe 1963). 
Antibiotics such as streptomycin, chloramphenicol, and tetracycline were 
subsequently introduced in the treatment of the sulphonamide-resistant 
organisms. Nonetheless, Shigella and Escherichia coli strains bearing resistance 
to the aforementioned agents were identified in 1955 (Alekshun and Levy 2007).  
The rapid acquisition and dissemination of resistance in few years were just the 
first signs of what was to come and led us to a point where at present, all known 
antibiotics currently available for clinical use in human and veterinary medicine 
have a resistance mechanisms reported (Bennett 2008; Harbottle et al. 2006). 
_____________________________________________________________________________________________ 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Moreover, the introduction of new classes or modifications of older classes of 
antimicrobials over the past six decades has been matched, slowly but surely, by 
the systematic development of new bacterial resistance mechanisms (Harbottle et 
al. 2006). We tend to forget that bacteria have inhabited the planet for 
approximately three and a half billion years, somewhat longer than mankind, and 
that they had to adapt on innumerable occasions to toxic substances suddenly 
introduced into their environments (Bennett 2008) (Figure 1). 
 
 
Figure 1 – Effect of the selective antibiotic pressure in bacteria (Mulvey and Simor 2009). 
 
Obviously, not all of the changes that allow this adaptation, for instance antibiotic 
resistance, are acquired by design (Bennett 2008; Harbottle et al. 2006; Walsh 
2006). The vast majority of these changes makes no improvement on the survival 
of an individual and are eliminated from the population over time, by a range of 
proofreading and DNA repair mechanisms (Boerlin and Reid-Smith 2008). 
However, those changes that confer advantage are conserved and, given 
appropriate circumstances, may undergo clonal amplification (Bennett 2008).  
 
Most likely, resistance genes and mechanisms allowing for their subsequent 
spread existed long before the discovery and introduction of modern therapeutic 
antimicrobials. For instance, antimicrobial resistant bacteria estimated to be over 
2000 years old have been recovered from glacial samples obtained from the 
Canadian Arctic Archipelago, while a more recent study detected TEM-type β-
lactamases from a metagenomic library of cold-seep sediments of deep-sea 
Edison seamount (near Papua New Guinea) estimated to be about 10,000 years 
old (Harbottle et al. 2006).    
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Evidence such as the emergence of organisms resistant to several antibiotics, 
including purely synthetic agents like quinolones, suggests not only that our 
surroundings can act as a reservoir for new resistance mechanisms, but also that 
the drugs used to treat infectious diseases have extended half-lifes outside of the 
hospital environment. In addition, many antimicrobial molecules have existed for 
millennia within the environment, selecting and promoting growth of resistant 
strains (Alekshun and Levy 2007).  
 
Over the years, the continued use of antibiotics generated an enormous selective 
pressure leading to organisms bearing additional resistance, and thus multi-drug 
resistance through changes in penicillin-binding proteins (PBPs), drug 
modification, drug destruction, mutated drug targets, enhanced efflux pump 
expression and altered membrane permeability (Figure 2) (Alekshun and Levy 
2007).  
 
 
Figure 2 – Antibiotics sites of action and microbial mechanisms of resistance (Mulvey and Simor 
2009). 
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In fact, resistance to both natural antimicrobial agents and synthetic derivates, as 
well as completely synthetic antimicrobials has been observed in soil-dwelling 
actinomycetes, with some, displaying resistance mechanisms not traditionally 
encountered in bacterial pathogens isolated from clinical environments (Harbottle 
et al. 2006). Surprisingly, researchers found every tested isolate to display 
resistance to at least six to eight different antimicrobial agents, and in some cases, 
as many as twenty (Harbottle et al. 2006). There appears to be a vast, yet broadly 
unknown reservoir of antimicrobial resistance genes lurking in natural 
environments, which may provide transferrable resources for other bacteria 
(Boerlin and Reid-Smith 2008).  
 
Moreover, the continuous use of antibiotics contributes to selective pressures that 
may ensure survival of a particular subset of genetic rearrangements; namely, 
those involving genes conferring antibiotic resistance. Whether these 
rearrangements occur in bacteria able to cause infection is, arguably immaterial. 
Once it is established, it can then amplify the selected rearrangement, and 
contribute for its dissemination under appropriate conditions (Bennett 2008). When 
these conditions are established, the selected rearrangement will subsequently be 
spread horizontally by plasmids to other bacteria, including human pathogens 
(Bennett 2008).   
 
 
 
 
 
 
 
 
 
 
 
 
  Introduction 
  21 
1.2. Antibiotics  
Although the boom of discovery and consequent use of antibiotics has 
happened in the beginning of last century, drugs have been used to the treatment 
of infectious diseases since the 17th century. However chemotherapy as a science 
began with Paul Ehrlich in the first decade of the 20th century, when he used an 
arsenic compound, salvarsan, to treat syphilis.  
 
Antibiotics can be defined as any compound either synthetic or naturally produced 
by fungi, plant or bacteria, which in a small quantity, can inhibit the growth of 
microorganisms or even kill them. The antibacterial activity of an antibiotic can be 
measured in vitro by determining the minimal inhibitory concentration (MIC). While 
some antibiotics merely inhibit the multiplication of bacteria and are therefore 
called bacteriostactic, others actively kill microorganisms thus having bactericidal 
activity.  
 
Antibiotics can be classified according to their chemical structure, biological origin 
and therapeutic use. In addition, most antimicrobial agents used for the treatment 
of bacterial infections may be categorised according to their principal mechanism 
of action (Tenover 2006). There are five general areas of bacterial metabolism that 
are targets for the development of new antimicrobials: cell wall synthesis, protein 
synthesis, RNA synthesis, DNA synthesis and intermediary metabolism (Table 1) 
(Hooper 2001).  
 
Antibiotics can also be classified according to their spectrum of action. Therefore, 
narrow-spectrum antibiotics act selectively against pathogens while broad-
spectrum antibiotics are effective against a wide-range of pathogens. 
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Table 1 – Antibiotics and their respective mechanisms of action (adapted from http://www.wiley.com). 
Antibiotic Mechanism 
Inhibitors of cell wall synthesis 
Carbanicillin Inhibits transpeptidation enzymes. Activates lytic enzymes of cell wall. 
 
Penincillin Inhibits transpeptidation enzymes. Activates lytic enzymes of cell wall. 
The affected bacterium will eventually lyse because the unsupported 
cell wall cannot withstand its growth. 
 
Vancomycin Inhibits transpeptidation in cross-linking peptidoglycans, interferes with 
bacterial cells at many levels, disrupting cell wall synthesis, interfering 
with RNA, and damaging the plasma membrane. 
 
Inhibitors of nucleic acid synthesis 
Ciprofloxacin Inhibits DNA gyrase; Interferes with DNA replication. 
 
Rifampicin Blocks RNA synthesis by binding and inhibiting RNA polymerase. 
 
Inhibitors of protein synthesis 
Chloramphenicol Blocks formation of new peptide bonds during protein synthesis by 
binding to the 50S subunit of the ribosome. 
 
Erithromycin  Binds the 50S subunit and blocks translocation of the new protein on 
the ribosome, thus effectively halting synthesis. 
 
Fusidic acid  Blocks translocation. 
 
Linezolid  Binds rRNA to prevent translation initiation and thus protein synthesis. 
 
Streptomycin  Binds the 30S ribosomal subunit of the bacteria and prevents the 
ribosome from forming the complex necessary to initiate protein 
translation. 
 
Tetracyclines Binds to the 30S subunit and blocks the addition of the amino acids, 
producing incomplete and probably non-functional proteins. 
  
Metabolic inhibitors 
Dapsone Interferes with synthesis of the folic acid, which is required for the 
synthesis of purines and thymidine and for the synthesis of the amino 
acids methionine and and glycine. 
 
Sulfonamides Competitively inhibits dihydropteroate synthase. These drugs can also 
be incorporated into a compound that resembles dihydrofolate and that 
in turn can inhibit another enzyme in the pathway, dihydrofate 
reductase. 
 
Trimethoprim  Inhibits dihydrofolate reductase, blocking tetrahydrofolate synthesis. 
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1.2.1 β-lactams 
 
β-lactam antibiotics represent the most diverse class of antibiotics that are 
widely used due to their spectrum of action, low toxicity and pharmacokinetic 
characteristics.There are six different groups (Figure 3)  into which they can be 
divided: penicillins, cephalosporins, carbapenems, cephamycins, monobactams 
and β-lactamase inhibitors (Smet et al. 2008). 
 
 
Figure 3 – β-lactams structure. Five classes are represented: 1) penicillins 2) cephalosporins, 3) 
monobactams 4) carbapenems, and 6,7,8) β-lactamase inhibitors (clavulanic acid, sulbactam and 
tazobactam) (Smet et al. 2008). 
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β-lactam antibiotics are bactericidal and are known to interact directly with PBPs 
forming covalent linkages, inhibiting the synthesis of peptidoglycan cross-linking, 
the main constituent of the cell wall. The structural profile and chemical 
composition of cell walls are very similar between Gram-negative and Gram-
positive bacteria. However, the main difference is related to the structural 
component that ensures the mechanical strength of the cell wall – the 
peptidoglycan (or murein). This heteropolymer consists of linear chains of two 
amino sugars, N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM), 
evidenced in figure 4, arranged alternately and joined by glicosydic bonds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 – A schematic representation of the peptidoglycan structure. The NAM and NAG sugars are 
shown as green and blue spheres respectively. The tetrapeptides linked to NAM are cross-linked by a 
pentaglycine peptide, shown as red lines linking the D-glutamine (L) to the D-alanine (A) 
(http://www.scq.ubc.ca/prescription-antibiotics-how-exactly-do-these-drugs-work/). 
 
β-lactams as transpeptidase inhibitors block the conversion of immature to mature 
peptidoglycan, thereby inhibiting enlargement of the bacterial cell wall (Hooper 
2001). They are preferred not only because of their efficacy and safety, but also 
because their activity can be extended or restored by chemical manipulation. No 
other antibiotic class has such chemical malleability and versatility (Livermore and 
Woodford 2006). Inevitably, however, their heavy usage had devastating 
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consequences as it ultimately selected for resistance. The first penicillin-resistant 
Staphylococcus aureus was identified in the mid-1940s and expressed a β-
lactamase that afforded resistance to penicillin’s (Alekshun and Levy 2007; 
Hawkey 2008). With the development of semi-synthetic penicillins (e.g. ampicillin 
and carbenicillin) in the early 1960s, the problem of resistance was overcome or, 
at least, postponed. However, their application was soon compromised by the 
spread of plasmid-mediated penicillinases (notably TEM-1) among 
Enterobacteriaceae (Abraham and Chain 1940).   
 
A major breakthrough was achieved against β-lactamase mediated bacterial 
resistance, with the introduction into clinical practice of the third-generation 
extended-spectrum cephalosporins (e.g. cefotaxime and ceftazidime). In the early 
1980s, when cephalosporins were introduced, virtually all Enterobacteriaceae 
were susceptible (Hawkey 2008; Livermore and Woodford 2006; Paterson and 
Bonomo 2005). Third-generation cephalosporins were strongly effective against 
most β-lactamase-producing organisms and had also the major advantage of 
narrowed nephrotoxic effects compared to aminoglycosides and polymyxins 
(Paterson and Bonomo 2005). These properties were fully explored in the 
subsequent 25 years, and have become antibiotics of choice worldwide. Once 
again, clinical use and/ misuse has selected for resistance and this cephalosporin 
resistance, along with dramatically rising enterobacterial resistance to 
fluoroquinolones, is now driving the use of carbapenems. Unfortunately, 
carbapenem resistance will not take long to emerge. In fact the use of 
carbapenems is very much under threat, especially in P. aeruginosa (Livermore 
and Woodford 2006).  
 
β-lactamases are the main cause of resistance to β-lactam antibiotics in Gram-
negative bacteria, and are increasing among clinical isolates, therefore 
compromising β-lactam usage. These enzymes are either chromosomally or 
plasmid and transposon mediated, and inactivate β-lactams by hydrolyzing the 
four-membered β-lactam ring, rendering the compound inactive (Smet et al. 2008).  
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1.2.1.1 β-lactamases 
 
  Antibacterial drugs can be altered by enzymes which can be divided into 
general classes: those such as β-lactamases that degrade antibiotics, and others 
(including the macrolide and aminoglycoside-modifying proteins) that perform 
chemical alterations (Alekshun and Levy 2007). Given the great diversity of 
enzymes produced, β-lactamases are commonly classified according to either 
molecular or functional properties. Based on these two properties two general 
schemes of classification were proposed: the Ambler molecular classification 
scheme and the Bush-Jacoby-Medeiros functional classification system (Bush et 
al. 1995; Queenan and Bush 2007).  
 
The Ambler scheme divides β-lactamases into four major classes (class A, B, C, 
and D), relying upon the basis of their primary structure and not on phenotypic 
characteristics, despite lacking the detail concerning the enzymatic activity of the 
enzyme. In this scheme, classes A, C and D include β-lactamases with serine on 
their active site, whereas class B enzymes are metallo-β-lactamases with zinc on 
their active-site (Paterson and Bonomo 2005; Queenan and Bush 2007).  
 
Isolation of the protein and determination of its isoelectric point, followed by 
enzymatic studies to determine substrate hydrolysis and inhibition characteristics, 
were the biochemical procedures used in the analysis of a new β-lactamase 
(Paterson and Bonomo 2005; Queenan and Bush 2007). Therefore, the relative 
hydrolysis rates of a broad spectrum of β-lactam substrates, and inhibitor profiles, 
allowed for the classification of a new β-lactamase. This functional classification 
scheme, proposed by Bush-Jacoby-Medeiros, evolved over many years into a 
widely accepted scheme currently dividing the known β-lactamases into four major 
functional groups (groups 1 to 4). Group 2 has multiple subgroups that are 
differentiated according to group-specific substrate or inhibitor profiles (Paterson 
and Bonomo 2005; Queenan and Bush 2007). 
  Introduction 
  27 
In particular, extended spectrum β-lactamases (ESBLs) of Bush-Jacoby-Medeiros 
group 2be, capable of conferring resistance to the penicillins, first-, second- and 
third-generation cephalosporins and aztreonam, that are also inhibited by 
clavulanic acid, have been thoroughly examined (Paterson and Bonomo 2005). 
The term ESBL is now under considerable debate and new classification criteria 
have been proposed to accommodate ESBLs with carbapenemase activity as well 
as class C and class D enzymes (Giske et al. 2009). ESBLs were first described in 
the mid-1980s. Earlier examples were derived from TEM-1, TEM-2 or SHV-1 
differing from their ancestors by as few as one amino acid. This substitution 
resulted in a profound change in the enzymatic activity of the ESBLs, enlarging 
their hydrolytic capacity, so that they can now hydrolyze the third-generation 
cephalosporins or aztreonam (Livermore and Woodford 2006; Paterson and 
Bonomo 2005). As ESBLs are inhibited by clavulanic acid they can be 
differentiated from the AmpC-type β-lactamases (group 1) produced by organisms 
such as Enterobacter cloacae which have third-generation cephalosporins as their 
substrates, but are not inhibited by clavulanic acid (Paterson and Bonomo 2005). If 
a plasmid carries both an AmpC gene and an ESBL gene, the detection of the 
latter can be difficult; this requires the use of AmpC-stable cephalosporins, such 
as cefepime or cefpirome with clavulanate or boronic acid as inhibitors, although 
detection is not 100% reliable even when using these combinations (Hawkey 
2008; Livermore and Woodford 2006).  
 
 
1.2.1.1.1 SHV β-lactamases  
 
SHV refers to sulhydryl variable. The inhibition of SHV activity by p-
chloromercuribenzoate was thought to be substrate-related, and variable 
according to the substrate used for the assay, thereby the term SHV (Paterson 
and Bonomo 2005).  
 
In 1983, a Klebsiella ozaenae isolate was discovered in Germany, that possessed 
a β-lactamase which efficiently hydrolyzed cefotaxime and to a lesser extent 
ceftazidime (Paterson and Bonomo 2005). This β-lactamase, designated SHV-2, 
_____________________________________________________________________________________________ 
 28 
 
differed from SHV-1 by the replacement of glycine by serine at the position 238, 
and this mutation alone accounts for its extended-spectrum properties. 
Enterobacteriaceae outbreaks associated with SHV-type ESBLs have been 
reported, and have also been detected in P. aeruginosa and Acinetobacter spp. 
(Paterson and Bonomo 2005). 
 
 
1.2.1.1.2 TEM β-lactamases 
 
More than 170 TEM-type β-lactamases have been described, the majority 
of them are ESBLs. The TEM-type ESBLs are derivates of TEM-1 and TEM-2, and 
the amino acid changes in comparison with TEM-1 and TEM-2 are well 
documented at http://www.lahey.org/studies/temtable.html (Paterson and Bonomo 
2005) . TEM-1 was first reported in 1965 from an E. coli isolate from a patient in 
Athens, Greece, named Timoneira (hence the designation TEM) (Paterson and 
Bonomo 2005). TEM-1 enzyme is now the commonest β-lactamase found in 
Enterobacteriaceae. The bla gene encoding the TEM-1 β-lactamase is the most 
frequently found AmpR marker used in molecular biology (pBR and pUC plasmids). 
TEM-1 is a widespread plasmidic β-lactamase that attacks narrow-spectrum 
cephalosporins, cefamandole, and cefoperazone and all the anti-Gram-negative 
bacterium penicillins except temocillin. In 1987, a plasmid harbouring a β-
lactamase, at the time termed CTX-1 based on its enhanced activity against 
cefotaxime, was detected in Klebsiella pneumoniae isolates collected as early as 
1984, in France (Paterson and Bonomo 2005). Today, CTX-1 is termed TEM-3, 
and differs from TEM-2 by two amino acid substitutions (Paterson and Bonomo 
2005). 
  
1.2.1.1.3 CTX-M β-lactamases 
 
Recently, a surprisingly fast disseminated and vast group of extended-
spectrum β-lactamases has gained the attention of microbiologists worldwide 
(Rodriguez et al. 2004). These β-lactamases are named CTX-M enzymes with 
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CTX reflecting the potent hydrolytic activity against cefotaxime. This family of 
plasmid-mediated ESBLs has been classified in the Ambler class A and in group 
2be of the Bush, Jacoby and Medeiros classification (Eckert et al. 2006). 
Organisms producing CTX-M-type β-lactamases typically have cefotaxime MICs in 
the resistance range (>64 µg/mL), while ceftazidime MICs values are usually in the 
apparently susceptible range (2 to 8 µg/mL) (Livermore and Woodford 2006; 
Paterson and Bonomo 2005). However, some CTX-M-type ESBLs can hydrolyze 
ceftazidime resulting in resistance. These enzymes hydrolyze cefepime with high 
efficiency, and contribute to cefepime MICs higher than those observed in bacteria 
producing other ESBLs types (Eckert et al. 2006; Paterson and Bonomo 2005).  
 
CTX-M enzymes include more than sixty variants that are distributed into five 
different clusters (CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25) 
according to their amino-acid sequence (Eckert et al. 2006; Su et al. 2008). Figure 
5 shows a world distribution of the majority of the aforementioned clusters. 
 
 
Figure 5 – Global distribution of the different CTX-M enzymes clusters (Cantón and Coque 2006).  
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Several reports have shown that Kluyvera spp., although a genus of little clinical 
relevance, carried the probable ancestor CTX-M enzymes. These enzymes 
evolved from chromosomal β-lactamase genes from Kluyvera spp., which the 
mobilization was facilitated by the insertion sequence ISEcp1 or related insertion 
sequences (Livermore and Woodford 2006; Paterson and Bonomo 2005; 
Rodriguez et al. 2004). Thus, it is safe to conclude that the rapid dissemination of 
blaCTX-M genes involves plasmid or strain epidemics, as well as mobile genetic 
elements (Bae et al. 2008). 
 
 
1.2.2 Quinolones 
 
As mentioned before, antibiotics can be isolated and synthesized from 
plant, fungi and bacteria. However unlike some of the first antibiotics discovered 
during the past century, quinolones were not isolated from living organisms but 
they are rather synthesized by chemists (Andriole 2005). Nalidixic acid (Figure 6) 
was the first compound to be produced in 1962, when it was accidently discovered 
as a by-product of the synthesis of chloroquine, an antimalarial compound 
(Andriole 2005).  
 
 
 
 
 
 
 
 
 
Figure 6 – Structure of nalidixic acid molecule (http://www.bmb.leeds.ac.uk/mbiology dna.html). 
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After the discovery of nalidixic acid, quinoles undergone several modifications to 
enhance their performance, creating analogous antibacterial agents. In fact, a key 
finding in the evolution of quinolones was the modification of the quinolone 
nucleus through the addition of different substituents at the N-1 (cyclopropyl 
group), C-6 (fluorine atom), C-7 (piperazine group) and C-8 (fluorine or a chlorine) 
(Andriole 2005).   
 
Quinolones and fluoroquinolones are bactericidal antibiotics, commonly 
prescribed, that have been widely used in medicine due to their broad efficacy, 
immunomodulatory activities and also because they can be administrated orally 
(Kim et al. 2009a; Toleman et al. 2006b). They act against DNA metabolism 
inhibiting DNA synthesis, and at higher concentrations, RNA synthesis as well. 
Their primary targets are bacterial enzymes DNA gyrase and topoisomerase IV 
(Figure 7). The ability of quinolones to interact with these two targets within the 
bacterial cell, by stabilizing complexes of DNA and Type II and IV topoisomerases, 
mediated the effects on DNA metabolism (Andriole 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 – Primary targets of quinolones in Gram-negative and Gram-positive bacteria 
(http://www.sbimc.org). 
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However, under new selection pressures, bacterial populations may respond with 
new mutations. Such mutations result in bacteria selection, in which new 
advantageous characteristics, are more prone to emerge in mutator than in non-
mutator strains (Boerlin and Reid-Smith 2008). This mechanism is thought to play 
a role in the emergence of mutations leading to resistance to the antimicrobial 
agents, such as fluoroquinolones (Boerlin and Reid-Smith 2008). These mutations 
can gradually accumulate in most bacteria, mediating high-level fluoroquinolone 
resistance. Point mutations in the genes encoding DNA gyrase sub-units can alter 
the binding efficiency of quinolones, thereby reducing their efficacy or even 
preventing it (Kim et al. 2009b). Multiple mutations in the quinolone resistance 
determining region (QRDR) of genes such as gyrA, gyrB, and parC, cause an 
increase in the MICs values, and consequently decreased susceptibility to 
quinolone antimicrobials (Harbottle et al. 2006). Furthermore, in 
Enterobacteriaceae, topoisomerase based resistance to quinolones occurs 
generally in a two- step mutation process with moderate levels of resistance. The 
first mutation in the QRDR of the primary target, gyrA gives full resistance to 
narrow-spectrum quinolones, such as nalidixic acid, and decreased susceptibility 
to fluoroquinolones. Once established, higher levels of resistance may occur from 
additional mutations in one of the gyr or par genes, giving full resistance to 
fluoroquinolones (Nordmann and Poirel 2005; Smet et al. 2008). However, the 
primary drug target enzyme as defined by first-step quinolone resistance 
mutations often differs between Gram-positive and Gram-negative bacteria 
(Hooper 2001).   
 
In compounds that are isolated from living organisms, sooner or later, mechanisms 
of resistance are expected to arise. However, as fluoroquinolones are, fully 
synthetic, naturally evolving antimicrobial resistance genes have not been 
considered a threat. Moreover, when quinolones were discovered, it was thought 
that this problem would take many years to occur since the bacteria exposed to 
these compounds would not have the ability to survive in their presence. Once 
again, the bacteria ability to adapt was underestimated.  
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A recently discovered example of enzymatic alteration of a synthetic antimicrobial 
involves the plasmid-borne variant of the original aminoglycoside 6´-N-
acetyltransferase, (AAC(6’)-Ib-cr) that acetylates fluoroquinolones and reduces 
their activity (Harbottle et al. 2006; Kim et al. 2009b; Lascols et al. 2008; Robicsek 
et al. 2005b). Although the aac(6’)-Ib-cr causes low-level resistance to 
ciprofloxacin, this gene was shown to act additively with another plasmid mediated 
quinolone resistance (PMQR) mechanism qnrA, and the mutant prevention 
concentration was significantly altered (Kim et al. 2009b; Robicsek et al. 2005b). 
Additionally, qepA, which encodes an efflux pump belonging to the major facilitator 
subfamily, was found in a plasmid, and also confers quinolone resistance 
(Perichon et al. 2007; Yamane et al. 2007).  
 
Another example, already mentioned above, that has been reported worldwide is 
the plasmid-mediated quinolone resistance encoded by qnrA, qnrB, qnrC, qnrD or 
qnrS (Aihua et al. 2008; Cavaco et al. 2009; Jacoby et al. 2008; Nordmann and 
Poirel 2005). Qnr proteins are members of the pentapeptide family, that are able to 
protect topoisomerases reducing their susceptibility to fluoroquinolones and 
increasing the mutant selection window, ultimately increasing the selection of 
resistant mutations (Cavaco et al. 2007b; Nordmann and Poirel 2005). qnrA was 
the first qnr gene described in a K. pneumoniae in 1998 by Martinez et al, 
(Martínez-Martínez et al. 1998). It has subsequently been shown to be widely 
distributed and is always part of a complex sul1-type integron containing ISCR1 
(Park et al. 2007). qnrS was first described in Shigella flexineri in 2005 and qnrB in 
2006 in K. pneumoniae and E. coli (Lascols et al. 2008). qnrC and qnrD were 
reported in Proteus mirabilis and in a Salmonella enterica strain respectively 
(Cavaco et al. 2009). Subsequent reports have shown that these genes are also 
present in other species of Enterobacteriaceae and have been found in many 
countries from Europe, Asia and the United States of America (Lascols et al. 2008; 
Robicsek et al. 2006). Transferrable qnr genes are usually carried by large 
conjugative plasmids (50 to 180kb) that often encode ESBLs or AmpC-type β-
lactamases (Lascols et al. 2008).  
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Based on this strong association between qnr genes and plasmids carrying 
cephalosporinase genes, ceftazidime resistance is often an inclusion criterion for 
selection of strains carrying a qnr gene (Robicsek et al. 2006). The dissemination 
of plasmids carrying qnr genes can potentiate the rapid development of higher 
level of quinolone resistance in organisms currently classified as susceptible 
(Robicsek et al. 2005b). In fact, a recent study associates quinolone resistance in 
Enterobacteriaceae with an increasing prevalence and diversity of PMQR genes in 
isolates collected consecutively during a given timeframe (Kim et al. 2009a; Kim et 
al. 2009b).   
 
Quinolones were a useful resource to fight MDR isolates, but still highly 
susceptible to fluoroquinolones. These isolates would have been expected to have 
a low likelihood for the emergence of quinolone resistance (Kim et al. 2009a).  
The rapid emergence of PMQR, together with the increasing use of 
flouroquinolones, created the opportunity of highly quinolone-resistant clinical 
isolates to arise, reducing the already narrow window of therapeutic options. 
 
 
1.2.3 Aminoglycosides  
Aminoglycosides are a very heterogeneous group in their chemical 
composition, pharmacological properties and antibacterial properties. They are 
also among the most commonly used broad-spectrum antibiotics to treat infectious 
diseases caused by Gram-negative bacteria (Galimand et al. 2003; Kotra et al. 
2000; Shakil et al. 2008; Toleman et al. 2006b). The aminoglycosides are very 
valuable as anti-infectives, since a vast majority exhibits bactericidal activity, have 
predictable pharmacokinetics, and often act in synergy with other antibiotics (Kotra 
et al. 2000; Shakil et al. 2008). Furthermore, unlike other classes of antibiotics, 
several aminoglycosides have been employed in clinical use for several decades 
(Kotra et al. 2000). 
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Agents belonging to this class of antibiotics act either at the level of bacterial 
protein synthesis by blocking the ribosome subunits irreversibly or by disrupting 
the integrity of bacterial cell membrane (Galimand et al. 2003; Shakil et al. 2008). 
Resistance, due to chromosomal mutations, is uncommon in this class of 
antibiotics even though the binding site for aminoglycosides is in the rRNA 
(Alekshun and Levy 2007; Kotra et al. 2000). Absence of alterations in the rRNA is 
predictable given the fact that its central function is protein biosynthesis and that 
this function is so well preserved across genera that it cannot be impaired by the 
possibility of such structural mutations (Kotra et al. 2000). However, 
aminoglycosides resistance does exist and has been widely reported, although not 
on the same scale as the resistance to β-lactam antibiotics (Kotra et al. 2000). 
Resistance to these compounds results from the action of a vast number of 
aminoglycoside-modifying enzymes specified by genes on transferable elements 
that are widely spread in clinically relevant organisms. Many of these enzymes are 
found on integrons and other mobile elements where they associate with 
additional resistance determinants (Alekshun and Levy 2007).  
 
Aminoglycosides resistance occurs due to four major mechanisms: (a) the 
deactivation of aminoglycosides by proteins that N-acetylate (acetyltransferases), 
phosphorylate (phosphotransferases) and adenylate (nucleotidyltransferases) the 
compounds. The acetyltransferases are capable of modifying tobramycin, 
gentamicin, netilmicin and amikacin; the nucleotidyltransferases proteins alter the 
activity of tobramycin; and the phosphotransferases affect amikacin susceptibility 
(Alekshun and Levy 2007; Kotra et al. 2000). (b) the reduction of the intracellular 
concentration of aminoglycosides by changes in outer membrane permeability, 
decreased inner membrane transport, active efflux and drug trapping (Kotra et al. 
2000; Shakil et al. 2008); (c) the alteration of the 30S ribosomal subunit target by 
mutation and (d) methylation of the aminoglycoside binding site (Shakil et al. 
2008).   
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1.2.4 Sulfonamide and Trimethoprim 
 
The discovery of sulfonamides occurs in 1932; however, it was only 
published in 1935. Sulfonamides were the first antimicrobials developed for large-
scale production into clinical practice. Their discovery pales only in comparison 
with that of Fleming’s chance to discover penicillin, as the initial antibacterial 
activity was not proven to be in vivo (Alekshun and Levy 2007; Tenover 2006). 
The drug had no effect at all in the test tube; however, in the living body it was 
found to act as a prodrug being released from the inactive dye as a small, 
colourless and active compound. Sulfonamides can be used in combination with 
another drug, trimethoprim, producing a synergistic antibacterial effect by inhibiting 
successive steps in the folate synthesis (Figure 8). The combination of the two 
drugs is known as co-trimoxazole. 
 
Trimethoprim, introduced in 1968, inhibits dihydrofolate reductase and 
consequently inhibits synthesis of tetrahydrofolic acid, which is an essential 
precursor in the de novo synthesis of the intermediate thymidine monophoshpate 
(dTMP), precursor of the DNA metabolite thymidine triphosphate (dTTP).  
 
Laboratory experiments using E. coli, Streptococcus pneumoniae and clinical 
isolates of Campylobacter jejuni and Haemophilus influenzae showed that 
mutations in the gene specifying dihydropteroate synthase decrease the enzyme’s 
affinity for the sulfonamides (Alekshun and Levy 2007). Additionally, mutations in 
the chromosomal gene specifying dihydrofolate reductase can result in over-
expression of an enzyme with reduced affinity for trimethoprim and thereby offer 
very high-level trimethoprim resistance in E. coli and H. influenzae (Alekshun and 
Levy 2007). 
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Figure 8 – Sites of inhibition of folic acid metabolism by sulfonamides and trimethoprim 
(http://pathmicro.med.sc.edu/mayer/antibiot.htm). 
 
The synergetic effect of co-trimoxazole is also affected by the acquisition of genes 
specifying enzymes that are insensitive to drug inhibition. Among these genes, 
sul1 and sul2 are the main determinants of clinical resistance to sulfonamide, 
whereas sul3 was found to be prevalent in farm animals (Alekshun and Levy 
2007). 
 
dfr genes are responsible for trimethoprim resistance and more that 20 variants 
have been described. sul genes are present on class 1 integrons (sul1) or 
plasmids (sul2) and associated with ISCRs, whereas dfr variants move from 
organism to organism on class 1 and 2 integrons. dfr1 is the most common in 
Gram-negative bacteria and is present on the Tn7 transposon, thereby permitting 
its integration into the E. coli chromosome (Alekshun and Levy 2007).   
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1.3 Bacterial resistance mechanisms  
Bacteria can avoid potentially toxic compounds that threaten their survival 
using single or combined mechanisms of resistance involving different elements 
(Figure 9); all they need is time to adapt to the changes in their surroundings. 
Therefore, throughout history, there has been a continual battle between humans 
and the plethora of microorganisms causing infection and disease (Tenover 2006).  
 
 
1.3.1 Intrinsic resistance  
 
The mechanisms used to attain resistance can be either intrinsic or 
acquired. Usually resistance due to the former can be described as a natural 
phenomenon displayed by all members of a species, and is a function of 
physiological or biochemical makeup of that species (Boerlin and Reid-Smith 
2008; Harbottle et al. 2006; Tenover 2006). In such cases, all strains of that 
bacterial species are likewise resistant, or can be potentially resistant, to all the 
members of those antibacterial classes (Tenover 2006). AmpC β-lactamase genes 
of Gram-negative bacteria and many MDR efflux systems are examples of intrinsic 
resistance occurring naturally on the host’s chromosome (Alekshun and Levy 
2007). Moreover, a decreased binding affinity to the PBPs makes Enterococci 
intrinsically resistant to cephalosporins (Harbottle et al. 2006).  
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Figure 9 – Different elements involved in the spread of antibiotic resistance genes (Boerlin and Reid-
Smith 2008). 
 
 
Another classic example is the Mycoplasm genera, which lacks cell wall thereby is 
naturally resistant to all the β-lactams, since they have the cell wall as target. This 
kind of resistance is predictable and should not affect therapeutic options. 
Although, it does requires laboratory technicians and clinicians possessing a prior 
knowledge of these mechanisms. Resistant mutants can multiply and emerge out 
of the overall anonymity due to the interplay between the occurrence of random 
mutations and selective antimicrobial pressure (Boerlin and Reid-Smith 2008). 
 
 
1.3.1 Acquired resistance 
 
Extrachromosomal elements are the predominant factor for the escalation 
of antibiotic resistance. The capture of genetic information encoding resistance 
new to the cell from an outside source, usually another bacteria, expands the  
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genome (Alekshun and Levy 2007; Bennett 2008; Boerlin and Reid-Smith 2008; 
Tenover 2006; Toleman et al. 2006b). Acquired resistance differs from intrinsic in 
that the former is not present in the entire species but only within a certain lineage 
of bacteria derived from a susceptible parent (Bennett 2008; Harbottle et al. 2006). 
Also, acquired resistance can be divided in vertical and horizontal evolution 
according to the mechanism of acquisition. The horizontal evolution may occur 
between strains of the same species or between different bacterial species or 
genera (Tenover 2006). Acquired mechanisms involve transfer of resistance 
determinants borne on plasmids, bacteriophages, transposons and also other 
mobile genetic material. Some bacteria can display both mutations and transfer of 
resistance, i.e, examples of intrinsic and acquired resistance. This event may 
occur through one of several processes including transduction (via 
bacteriophages), conjugation (via plasmids and conjugative transposons) and 
transformation (via incorporation into the chromosome of chromosomal DNA, 
plasmids and other DNAs from dead organisms) (Alekshun and Levy 2007; Boerlin 
and Reid-Smith 2008; Summers 2006). 
 
 
1.4 Mechanisms of resistance gene transfer  
1.4.1 Transformation  
Transformation is the longest known mechanism of DNA transfer among 
prokaryotes (Figure 10). It starts with the release of DNA from a bacterium (donor 
cell) after death and lyses, or in some bacteria, at a specific point in the growth 
cycle (Harbottle et al. 2006; Summers 2006). Competent recipients can take up 
the DNA that was release in the surrounding environment after being degraded 
and broken into smaller fragments. The degraded DNA may include antibiotic 
resistance genes which can be taken up by nearby bacterium, undergo 
homologous recombination and incorporated into the bacterial genome (Harbottle 
et al. 2006). 
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Therefore, heterologous genes would not be able to recombine and would be 
degraded by the recipient’s nucleases, which confines transformation to the 
transfer of variants (alleles) of shared chromosomal genes among strains of a 
bacterial species (Summers 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 – Description of the alteration of a bacterial cell genome by the uptake of naked, foreign 
DNA from the surrounding environment. Example of acquisition of ampicillin resistance (Adapted 
from http://www.1lecture.com/Microbiology/Bacterial%20Transformation/index.html). 
  
1.4.2 Transduction  
 
Transduction is a process carried out by bacteriophages that involves 
infection of a bacterium, phage replication and packaging of some of the bacterial 
DNA with the phage DNA (which may include resistance determinants), lysis of 
that bacterium and infection of subsequent bacteria. Upon subsequent infection, 
those resistance determinants may be transferred to the infected bacterium 
(Harbottle et al. 2006; Summers 2006).  
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More specifically, there are two possibilities that bacteriophages can undertake 
upon infecting a cell: either to integrate into the host’s chromosome or to replicate 
themselves and lyse the cell. The former option sets the phage up to carry some 
of the host’s DNA when it eventually replicates. However, in some cases, the 
phage accidentally package only host cell DNA when they replicate. In either case, 
the resulting phage particles attach and inject the DNA they have packaged into a 
new host. The chromosomal DNA introduced by the phage will be degraded 
unless it recombines with homologous regions on the resident chromosome 
(Figure 11). Thus, like transformation, bacteriophage-mediated transduction is 
usually successful only in transferring alleles of homologous genes among closely 
related bacteria. And while bacteriophages frequently carry toxins and other 
virulence factors, it is rare for them to carry antibiotic resistance genes (Summers 
2006). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 – Transduction process. 1) Phage injects its DNA 2) Phage enzymes degrade host DNA 3) 
Cell synthesizes new phage that incorporate phages DNA and mistakenly some host DNA 5) 
Transducing phage injects donor DNA 6) Donor DNA is incorporated into recipient’s chromosome by 
recombination (www.search.com/reference/Transduction_(genetics). 
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1.4.3 Conjugation 
 
Conjugation is carried out by double stranded DNA plasmids encoding a 
mating apparatus which includes both combined grappling hook and mating tube 
called a pilus, as well as a membrane mounted, energy-consuming DNA pump. 
This mating apparatus transfers a single strand of the plasmid DNA from the donor 
cell to the recipient cell, where the complementary is synthesized (Figure 12) 
(Summers 2006). When a resistance plasmid encodes the functions necessary to 
promote cell-to-cell DNA transfer, particularly their own transfer it is called 
conjugative. In contrast, others are mobilizable when helped by a conjugative 
plasmid co-resident in the cell. In general, mobilizable plasmids lack the genes 
that encode the functions that enable cells to couple prior to DNA transfer but do 
encode functions needed specifically for transfer. Particularly between Gram-
negative bacteria conjugative plasmids tend to be somewhat larger, 30 kb or more, 
reflecting the sizable amount of DNA (20–30 kb) needed to encode the 
conjugation functions that permit cell-to-cell coupling (Bennett 2008). An external 
hair-like transfer appendage, a sex pilus, mediates the coupling, acting like a 
grappling hook to join donor and recipient cells. To effect envelope-to-envelope 
contact, when a DNA transfer pore forms to bridge the cytoplasmic compartments 
of the conjoined cells, the pilus is then retracted into the donor (Bennett 2008) 
 
Conjugative plasmids can either transfer smaller nonconjugative plasmids or 
integrate into the donor’s chromosome and transfer a copy of the entire several 
megabase molecule to the recipient cell. If the transferred DNA is homologous 
with the recipient chromosome it can recombine or it can remain associated with 
the plasmid, which can replicate independently in the recipient as it did in the 
donor. If the transfer DNA remains associated with the plasmid, this allows for the 
transfer of genes. These genes, that are completely unrelated to the recipient, still 
persist in it as they are physically linked with the self-replicating plasmid. Often, 
plasmids are vehicles of virulence factors including genes facilitating colonization 
of an animal or plant host and antibiotic resistance genes, notably in the form of 
transposons and integrons (Summers 2006). 
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Figure 12 – The conjugation process. Image represents the direct transfer of genetic material between 
bacterial cells joined by sex pili. (http://evolution.berkeley.edu/evolibrary/) 
 
 
1.5 Mobile genetic elements  
 
The rapid dissemination of resistance genes among different bacteria, is 
facilitated by mobile DNA elements which can transport them in tandem (Harbottle 
et al. 2006). Examples, are genes encoding plasmid-mediated β-lactamases that 
are usually located within or near mobile elements (Arduino et al. 2002; Wang et 
al. 2003). While located on bacterial plasmids, at least three fundamentally 
different recombination systems (transposons, gene cassettes and ISCRs), act to 
assemble and re-assort resistance genes. A particular resistance plasmid may 
result from any combination, but the operation of all these three mechanisms 
provides bacteria with an extremely powerful and flexible genetic tool box that is 
more versatile than previously thought (Bennett 2008; Toleman et al. 2006b). The 
various recombination systems enable bacteria with the necessary mechanisms to 
capture and re-assort a whole variety of resistance genes that they may need now, 
and in the future. The movement is random, and generally independent of drug 
use, but drug use provides a powerful selection for these events once they happen 
(Bennett 2008).  
 
There are two general types of mobile genetic elements: those that can move from 
one bacterial cell to another, which in terms of antibiotic resistance includes 
resistance plasmids and conjugative resistance transposons; and elements that 
can move from one genetic location to another whitin the same cell. The latter 
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include resistance transposons, gene cassettes and ISCR-promoted gene 
mobilization (Bennett 2008). The rapid dissemination of antimicrobial resistance 
among several bacterial genera of human and veterinary importance was 
facilitated by the spread of mobile genetic elements, in particular plasmids, 
transposons and integrons (Harbottle et al. 2006). Plasmid, transposon and 
integron-borne resistance to antibiotics now occurs in the majority of Gram-
negative pathogens isolated from hospitals and animal production facilities 
(Gillings et al. 2008). Studying the origin of the resistance determinants and the 
mobile elements that spreads them is critical to the understanding of resistance 
dissemination and attempting to control future recruitment and spread of 
resistance genes (Gillings et al. 2008).  
 
1.5.1 Plasmids 
 
As mentioned before, horizontal gene transfer involves movement of 
bacterial genes from one bacterial cell to another. The elements responsible for 
this movement are bacterial plasmids, specifically conjugative plasmids, which are 
able to promote their own transfer and the transfer of other plasmids from one 
bacterial cell to another (Bennett 2008; Carattoli et al. 2005). Plasmids are 
described as extra-chromosomal circular fragments of DNA (Figure 13) that exist 
separately from the main bacterial chromosome, and are capable of chromosome 
independent replication.  
 
 
Figure 13 – Diagram of a plasmid. P - promotor; RG - resistance gene; Ori - origin of replication. 
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Nevertheless, the host cell provides the majority of replication functions (Bennett 
2008; Carattoli et al. 2005). Moreover, plasmids are double-stranded DNA 
molecules, present in nearly all bacterial species, that vary in size from a few (7-8 
kb) to more than several hundred (>400 kb) kilobase pairs (Carattoli et al. 2005).  
 
As it has been observed, particular environmental circumstances may trigger the 
bacteria to use resources often provided by plasmids which carry useful genes 
(Bennett 2008; Harbottle et al. 2006). Hence, even though they are not essential 
for survival, plasmids can carry a considerable variety of genes, such as those 
conferring antibiotic resistance and resistance to a number of toxic heavy metals. 
Plasmids can also carry genes either providing enzymes that expand the 
nutritional ability of the cell or virulence determinants that permit invasion of and 
survival in animal systems, as well as functions that enhance the capacity to repair 
DNA damage (Bennett 2008; Carattoli et al. 2005). Plasmids carrying resistance 
genes are referred as R plasmids or R factors. Since their discovery in the 1950s, 
antimicrobial resistance plasmids have been increasingly found associated with 
both Gram-positive and Gram-negative bacterial pathogens and commensal 
organisms (Harbottle et al. 2006).  
 
The window of therapeutic options became narrow as plasmid-encoded antibiotic 
resistance encompasses most, if not all classes of antibiotics currently in clinical 
use, and includes resistance to many that are at the forefront of antibiotic therapy. 
A single plasmid can simultaneously mediate resistance to multiple first choice 
antibiotics such as cephalosporins, fluoroquinolones and aminoglycosides, and be 
shared among different bacterial genera (Bennett 2008; Harbottle et al. 2006). 
 
Since plasmids are very promiscuous elements, understanding the molecular 
epidemiology of resistance plasmids has proven to be a complex task (Hopkins et 
al. 2006). A formal scheme of plasmid classification is based on incompatibility 
(Inc) groups (Harbottle et al. 2006; Walsh 2006). Based on this scheme, their 
relatedness can be demonstrated either by restriction fragment pattern analysis or 
by classification into incompatibility groups (Inc) and replicon (rep) typing (Hopkins 
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et al. 2006). The origin of replication can be considered an additional marker for 
the constant backbone of the plasmid. Therefore, the association of replicons with 
specific plasmid borne resistance genes opens the possibility of easily detect and 
trace the diffusion of successful plasmids as well as the mobilization capability of a 
resistance gene among different plasmids (Hopkins et al. 2006). 
 
The introduction, by conjugation or transformation, of a plasmid of an unknown Inc 
group into a strain carrying a plasmid of a known Inc group is the basis of 
incompatibility grouping (Carattoli et al. 2005). Plasmids with the same replication 
control are termed “incompatible”, whereas plasmids with different replication 
controls are “compatible”. On this basis, two plasmids belonging to the same Inc 
group cannot be propagated within the same cell line (Carattoli et al. 2005).  
 
 
1.5.2 Transposons  
 
Transposons are among the structures that can be carried by plasmids and 
carry themselves resistance genes. They can be described as jumping gene 
systems moving both intra- and inter-molecularly, as they can move from one 
location on the chromosome to another or from the chromosome to a transmissible 
plasmid (Alekshun and Levy 2007; Bennett 2008; Harbottle et al. 2006).  
 
Transposons appear in many forms, distinguished by structure, genetic 
relatedness and mechanism of transposition, and can carry a multiplicity of 
resistance genes (Bennett 2008). Small cryptic elements called insertion 
sequences (IS), transposons and transposing bacteriophages, such as 
bacteriophage Mu, fit into a set of mobile elements called transposable elements 
(Bennett 2008). 
 
Despite belonging to the same set, these elements display some differences 
between them. For instance, a transposon differs from an IS in size and also 
because the former encodes at least one function that changes the phenotype of  
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the cell in a predictable fashion, for instance a resistance transposon confers 
resistance to a particular antibiotic(s) (Bennett 2008). Transposons are composed 
by an insertion sequences (IS), intervening DNA and the enzyme responsible for 
the transposition, called transposase (Figure 14). The terminal regions that 
participate in recombination specify a protein (e.g., transposase or recombinase) 
that allows the incorporation into and from specific genomic regions. 
 
 
 
 
Figure 14 – Schematic structure of transposon composed by inverted repeats, genes for transposition 
and structural genes (plantstudents.blogfa.com/post-130.aspx).  
 
This jumping set of genes encodes the enzymes and carries the genetic 
sequences required for movement located within the transposon to randomly jump 
from one genetic location to another (Harbottle et al. 2006). These structures that 
present this composition and can transmit a large number of resistance 
determinants in many different bacterial species, are called composit transposons. 
 
For each transposon there is: a pair of IS elements flanking the central region are 
very similar in sequence and can be either as direct repeats, offering the 
opportunity to migrate to another site, or inverted repeats, more genetically stable, 
to the section containing genes conferring antibiotic resistance; a central DNA 
sequence the expression of which alters the cell phenotype, yet it is not inherently 
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able to transpose or mediates transposition; and a transposase, that promotes 
transposition (Bennett 2008; Harbottle et al. 2006).  
 
Transposition to another location occurs by a two-stage homologous 
recombination process. At first, a circular, double-stranded DNA species 
comprising the central section of the composite resistance transposon and one 
copy of the IS element are released. This process occurs by the excision of part of 
the composite structure from its existing site by single crossover between the 
copies of the IS element, whereas one is released and the other remains at the 
original genetic location (Bennett 2008). A composite transposon can be recreated 
in a new location when the released DNA is rescued, essentially by reversing the 
first recombination, by homologous recombination involving a single crossover, 
using the copy of the IS sequence on the free intermediate and another copy at 
the new location (Bennett 2008). Moreover, the movement to the new location can 
be accomplished by insertion into a conjugative plasmid or via a conjugative 
transposon, being the latter unique as they have behave as plasmids and can 
facilitate the transfer of endogenous plasmids from one organism to another 
(Alekshun and Levy 2007; Harbottle et al. 2006). Unlike plasmids, the covalently 
closed single-stranded DNA circular structure that conjugative transposons form 
after promoting their excision from the donor cell’s genome, does not replicate 
except to synthesize a complementary strand to become double stranded. These 
transposons then promote their conjugation to a neighbouring bacterium and 
following conjugation, integrate into the recipient chromosome or the recipient 
host’s plasmid (Harbottle et al. 2006).  
 
Tn5 and Tn10 are well-known example of resistance transposons, encoding 
resistance to aminoglycosides such as kanamycin and neomycin, and resistance 
to tetracycline, respectively, and both can be found in a number of Gram-negative 
bacteria (Bennett 2008).  
 
Such structures are created by chance but conferring a distinct survival 
advantage, when they become established in the population. For instance, the 
selective forces operating on the bacterial flora, such as the exposure to  
_____________________________________________________________________________________________ 
 50 
 
kanamycin/neomycin or tetracycline respectively, may prompt for such 
establishment (Bennett 2008). Tn3 and Tn21, are examples of complex 
transposons commonly found in plasmids among Enterobacteriaceae. Tn3, 
encoding resistance to a number of β-lactams antibiotics, including ampicillin, and 
Tn21, encoding resistance to streptomycin, spectomycin and sulphonamides as 
well as mercuric ions (Bennett 2008). Some aspects of Tn21 construction can be 
deduced; however, the construction of this type of element is less easily explained 
and no general evidence-based model has been proposed yet.  
 
Complex transposons are probably the result of multiple recombination events. 
These events include both insertions and deletions, which first insert non-
transposition functions into a cryptic element and then refine the sequence by 
deletion to eliminate ‘non-essential’ functions (Bennett 2008). It has been verified 
that increasing the size of a particular transposable element reduces its frequency 
of transposition, therefore this refinement would assemble a compacted element 
and hence more readily transposable (Bennett 2008).   
 
 
1.5.3 Integrons  
Historically, transposons were considered to be the main vehicles of gene 
transfer between DNA molecules. Nevertheless, structures of some resistance 
transposons, such as Tn21-like transposons, are not fixed. For instance, it was 
discovered that they contain gene integration systems named integrons, capable 
of capture and re-assort individual resistance genes (Collis and Hall 1995). Hence, 
this novel system of antibiotic resistance genes movement, explains the 
magnitude of resistance development and dissemination (Harbottle et al. 2006). 
Integrons are mobile gene capture systems that utilize site-specific recombination 
instead of transposition mechanisms to integrate at a specific location (Bennett 
2008; Harbottle et al. 2006). A recombination system consisting of a gene, int, 
which encodes a site-specific recombination enzyme referred as integrase, and a 
proximal primary recombination sequence refered as attI site, compose the 
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functional platform of an integron. The integrase mediates recombination between 
the attI site and a secondary target named an attC site (or 59-base element 
[59be]) (Bennett 2008; Rowe-Magnus and Mazel 2001; Toleman et al. 2006b; 
Walsh 2006). The attC site is generally associated with a single Open Reading 
Frame (ORF) located in a structure termed gene cassette (Rowe-Magnus and 
Mazel 2001). A general representation of class 1 integrons is represented in 
Figure 15. The variety of gene cassettes present in the natural environments is 
massive, amounting thousands of distinctive cassettes (Gillings et al. 2008). Those 
exist as small, free circular DNA structures around 500-1000 bp, that are not 
expressed due to the lack of the promoter region (Toleman et al. 2006b). 
 
This condition is a transitional state within the mechanism that mediates cassette 
transfer from one integron to another or the reposition of gene cassettes within a 
particular integron (Bennett 2008; Harbottle et al. 2006). Downstream of the 
promoter-less resistance gene is often a 59 bp element that acts as the 
recombination site. The expression of a gene encoded by a cassette is facilitated 
by the insertion of the latter into the integron structure via the recombination 
process at the attI recombination site downstream from a promoter (Bennett 2008; 
Harbottle et al. 2006; Rodriguez-Martinez et al. 2006). Gene cassettes may 
generate remarkable resistance arrays being inserted one after the other into the 
integration site and after each insertion attI regenerates (Bennett 2008). Two or 
more are expressed in a polycistronic manner from the cassette promoter within 
5’-CS and such expression displays polarity. The order of the gene cassettes 
indicates the order of their addition being the one near the 5’-CS the latest 
addition, because each cassette is inserted at the same point (Bennett 2008).    
 
Integrons can be distinguished according to their integrase sequence and several 
classes of integrons have been reported. Class 1 integrons are the most frequently 
identified, specially among enteric isolates and also in a number of different 
genera (Harbottle et al. 2006). Class 1 integrons, have distinctive structure 
comprising two terminal invariable regions, termed conserved sequences (CS), 
and a highly variable central section (Collis and Hall 1995). As it has been referred 
while describing integrons in general, at one end is the 5’-CS, which 
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accommodates int, the cassette insertion site attI and the promoter from which 
cassette genes are expressed. At the other end is the 3’-CS, composed by part of 
the qacEΔ1 gene, that when intact confers resistance to quaternary ammonium 
compounds, followed by sul, a gene conferring resistance to sulphonamides 
(Partridge and Hall 2003). The gene cassettes of a particular integron are flanked 
by these CS regions originating the so-called variable region, being variable both 
in terms of length and sequence. This region necessarily varies as the identities 
and number of the gene cassettes changes from one integron to another (Collis 
and Hall 1995) .  
 
 
 
Figure 15 – Structure of a class 1 integrons. Open reading frames are represented by boxes, with the 
arrows indicating the direction of transcription. Solid black circles represent 59-base elements, and 
silver ellipses represent the attI1 site of the integron.   
 
Integrons are not static structures rather they are constantly evolving in order to 
provide bacteria with the tools that enable them to resist to newer antimicrobials. 
In addition, recent findings on integron diversity and evolution suggest that they 
are much more diverse than originally thought (Boerlin and Reid-Smith 2008). 
Large chromosomal arrays of gene cassettes encoding a diversity of functions, 
known as super integrons and containing hundreds of gene cassettes, including 
resistance gene cassettes, have been found in a number of bacterial species. 
However, where individual cassettes derive from is often unknown (Bennett 2008). 
The term “super integron” was introduced by Mazel et al. in 1998 (Mazel et al. 
1998), to describe integrons that have incorporated hundreds of gene cassettes. A 
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classical example is the superintegron (SI) that has been found in the Vibrio 
cholerae chromosome, which is 179kb long, and harbours 179 gene cassettes. 
Superintegrons are likely to play an important role in bacterial evolution. However 
the role played by the superintegron has not been fully investigated (Harbottle et 
al. 2006). A potential selection of superintegrons among other bacterial pathogens 
can be driven from their complex structure, presence of multiple gene cassettes, 
chromosomal integration, and possible co-integration of virulence factors 
(Harbottle et al. 2006). Usually, and although class 1 integrons contain less than 
five gene cassettes, the individual cassettes in the superintegrons arrays can 
migrate to these smaller integrons found on plasmids present in bacteria of clinical 
origin, expanding their variability (Bennett 2008; Gillings et al. 2008). The ability of 
class 1 integrons to gather diverse genes and their inherent mobility has led to 
their important role in the spread of resistance determinants through human 
ecosystems (Gillings et al. 2008)  
 
 
1.5.4 Insertion Sequence Common Regions (ISCRs)  
Scaling down the variety of genetic mobile elements based on their size, 
there are smaller elements than the above described, to which special attention 
should be given. 
Although the movement of resistance transposons and gene cassettes can 
account for much of the recombination involved in resistance plasmid construction, 
they fail to explain the spread of a substantial and growing subset of resistance 
(Bennett 2008; Toleman et al. 2006b). Recently, it has become perceptible the 
contribution of at least another recombination system to the assembly of banks of 
resistance genes on bacterial plasmids (Bennett 2008; Toleman et al. 2006b). 
These recombination systems involved in this aspect of plasmid evolution are 
referred as Insertion Sequences Common Region or ISCR elements (Bennett 
2008). When a specific sequence is found in different genetic locations it may be 
thought to be a transposable element. When that sequence is linked with a 
multiplicity of resistance genes, suspicion hardens that it is responsible for the 
movements of those genes (Toleman et al. 2006b). 
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 ISCR elements were first described as sequences associated with class 1 
integrons, yet somewhat distinct from them. The same sequence was commonly 
found downstream of the 3’ CS of class 1 integrons, therefore it became known as 
the common region, or CR, and termed in order to distinguish it from the 5’ and 
3’CS of class 1 integrons (Bennett 2008; Toleman et al. 2006b). In the early 1990s 
the first common regions, were discovered and reported. They were described as 
a DNA sequence of 2,154 bp, accommodating a single ORF and found in two 
complex class 1 integrons, In6 and In7 (Toleman et al. 2006b). Following a 
comparative analysis, it was perceptible that these CRs displayed a certain degree 
of relatedness to each other and bear a resemblance to an atypical class of 
insertion sequences, designated IS91-like (Chen et al. 2008; Toleman et al. 
2006b; Toleman and Walsh 2008; Walsh 2006). It is known for some time that 
IS91-like elements differ distinctly from most other IS elements in both structure 
and mode of transposition, and recently the ISCRs were found to exhibit the same 
characteristics (Bennett 2008). On the one hand, they lack terminal inverted 
repeats (IR), but possess distinct terminal sequences designated oriIS and terIS 
(Figure 16), that indicates the unique sites for the initiation and the termination, 
respectively, of the mechanism which by they are transposed (Bennett 2008; 
Harbottle et al. 2006; Toleman et al. 2006b).  
 
 
 
 
 
 
 
 
Figure 16 – oriIS and terIS-1 are denoted as the insertion and termination sites of ISCR1 transposition, 
respectively. Sequences underlined read 5'->3' for each site and the nucleotides in bold match those 
of the consensus sequence of IS91, IS1294 and IS801 The larger bold horizontal arrow indicates the 
direction (from right to left) and origin of replication (Toleman et al. 2006b).  
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One feature of these systems is that they seem to insert relatively randomly in any 
DNA molecule, meaning that virtually they can be inserted adjacent to any gene 
and transpose it. Moreover, and very important in the dissemination of antibiotic 
resistance genes, is that the termination mechanism of ISCRs replication is not 
very accurate, showing a degree of inaccuracy up to 10%, allowing replication to 
proceed beyond terIS and into adjacent sequence, where it appears to be 
terminated more or less at random (Bennett 2008; Harbottle et al. 2006). On the 
other hand, once the movement of these elements involves rolling-circle (RC) 
replication, therefore allowing rearrangements that may not be possible by 
traditional rearrangements, it is thought that these elements transpose by a 
mechanism termed RC transposition, (Harbottle et al. 2006). As a consequence, 
IS91-like elements can transpose adjacent DNA sequences, mediated by a single 
copy of the element, as the precedent given by IS1294, which was shown to 
mobilize the adjacent kanamycin-resistance gene by a single copy (Toleman et al. 
2006b; Walsh 2006).  
 
The mobilization is intrinsic to the RC transposition mechanism and will, in 
principle, mobilize any DNA following the replication terminal signal. Integrons that 
differ from the more common form of class 1 integrons, in the way that contain two 
copies of the 3´CS and a CR, are called complex class 1 integrons and their 
construction was predicted to be based on the RC transposition mechanism 
(Bennett 2008; Toleman et al. 2006b). Furthermore, it has also been argued that 
ISCRs are associated with the mobilization of virtually every class of antibiotic 
resistance gene, including those encoding extended-spectrum β-lactamases 
(ESBLs), carbapenemases, enzymes conferring broad-spectrum aminoglycoside 
resistance, as well as genes encoding resistance to 
floranphenicol/chloramphenicol, trimethoprim and quinolones (Toleman et al. 
2006b). 
 
Another interesting feature of ISCRs is that they are intimately associated with 
different resistance genes carried on each integron. In the case of In6, the CR is 
found immediately upstream of a chloramphenicol resistance gene (catAII), while 
the CR in In7 is associated with a novel trimethoprim resistance gene (dfrA10) 
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(Toleman et al. 2006b). A typical circumstance for the overwhelming majority of 
resistance genes embedded in class 1 integrons is their linkage with the 59 base 
elements (site-specific recombination sequences that define gene cassettes). 
However it was noticed with striking surprise that neither of these two CR-
associated resistance genes was linked to a 59 base elements as it would be 
expected (Toleman et al. 2006b). Therefore, a model was proposed, in which 
ISCR1 became associated with the 3’-CS of a class 1 integron, as a chance event 
which was followed by a second but aberrant transposition event that placed 
ISCR1, together with different lengths of the class 1 integron, alongside a variety 
of resistance genes (Bennett 2008; Toleman et al. 2006b).  
 
The RC transposition mechanisms generated free circular species containing 
ISCR1, whole or part of 3’-CS and a non-gene resistance cassette gene(s), from 
the former constructs. These intermediates were subsequently rescued by 
homologous recombination into other class 1 integron, using the common 3’-CS 
sequence as point of crossover (Bennett 2008). The process is almost complete 
and will be finalized with the mobilization of these constructs onto a conjugative 
plasmid and then via conjugation, into other species/genera of bacteria as shown 
in Figure 17 (Bennett 2008; Toleman et al. 2006b). The striking potential for 
movement between bacterial species displayed by ISCR elements became 
perceptible based on the observation that several, if not all, ISCR elements have 
migrated on to plasmids. Accordingly, a large percentage of the entire bacterial 
gene pool on the planet is potentially available for transposition on to bacterial 
plasmids, mediated by the ISCR (Bennett 2008). Since the first CR sequence was 
identified, several more have been discovered worldwide and ISCRs have now 
been found to be present on both plasmids and chromosomes in numerous Gram-
negative organisms of clinical importance, and in a few Gram-positive bacteria 
(Toleman et al. 2006b).  
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Figure 17 – Model of ISCR1-mediated construction of complex class 1 integrons. The construction of 
complex class 1 integrons can be explained by a three step mechanism. (A) Aberrant RC replication of 
the ISCR1 element (fused to 3’CS) generates transposition intermediates of different length. These 
intermediates then transpose adjacent to an antibiotic resistance gene (e.g. catA or qnr), in another 
location. (B) A second aberrant RC replication event produces circular intermediates which now 
include catA or qnr. (C) These circular intermediates can then be rescued by recombination events 
between 3’CS on another ‘normal’ class 1 integron (D and E) producing the complex integrons G and 
H, or they can be rescued by (F) a class 1 integron already including a copy of ISCR1 generating the 
complex integron I. Such aberrant RC transposition and recombination rescue events provide an 
explanation for the spectrum of complex class 1 integrons observed in nature. Boxes represent the 
open reading frames of the various genes with arrows indicating the direction of their transcription. 
The open reading frame of the ISCR1 elements is shaded in grey and the resistance genes that lack a 
59 base element are patterned. 
 
As already mentioned, ISCRs are notable for their close association with a wide 
variety of antibiotic resistance genes. At present, there are at least 19 members of 
the ISCR family, and all adjacent to genes that are not the natural complement of 
the host cell, the vast majority being antibiotic resistance genes (Toleman and 
Walsh 2008). Generally, they can be divided into two groups: those that form 
complex class 1 integrons (termed ISCR1), and those that are associated with 
non-class 1 integrons (ISCR2-19) (Toleman et al. 2006b).  
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ISCR1 it has been reported in association with genes encoding either resistance to 
chloramphenicol (catAII), trimethoprim (dfrA10, dfrA23, dfrA3b, dfrA19) or 
aminoglycosides (armA), as well as with class A β-lactamases (blaCTX-M-1, blaCTX-M-
2, blaCTX-M-9, blaCTX-M-20, blaPER-3, blaVEB-3) and class C β-lactamases (blaDHA-1, 
blaCMY-1, blaCMY-8, blaCMY-9, blaCMY-10, blaMOX-1) (Arduino et al. 2002; Boyd et al. 
2002; Di Conza et al. 2002; Partridge and Hall 2003; Sabate et al. 2002; Su et al. 
2008; Verdet et al. 2000). The recently discovered gene, qnr, is also closely linked 
to ISCR1 specially the qnrA1 allele (Chen et al. 2008; Garnier et al. 2006; 
Nordmann and Poirel 2005).  
 
ISCR2 (encompassing the gene known as orfA) is the primary representation of 
the second subgroup of ISCR elements. It is part of the MDR-encoding genetic 
element SXT, and is also encountered on numerous plasmids carrying 
chloramphenicol/florfenicol and sulfonamide resistance (Toleman et al. 2006b). 
While ISCR1 has until now been found as a component of complex class 1 
integrons, ISCR2 has never been associated with class 1 integrons but often 
associated with the sul2 gene (Toleman et al. 2006b). Nevertheless, its linkage 
with genes encoding resistance to trimethoprim (dfrA18, dfrA9, dfrA20) and 
tetracycline (tetR) has been reported. 
 
All the others ISCRs were described in particular genetic contexts, scattered 
worldwide and in different species. For instance, ISCR3 typifies the third subgroup 
of ISCR elements that as it has been happened before to other elements, was 
originally identified by the transposase gene, namely, orf2. To date, it has been 
associated with the SGI1 element (and variants thereof) and is also linked to an 
erm gene encoding erythromycin resistance and the rmtB gene enconding 
aminoglycoside resistance (Toleman et al. 2006b). qac, dfrA10, ereB, yieE and 
yieF are other examples of genes associated with ISCR3 . ISCR4, was first 
identified by its transposase gene, previously named orf495 (Poirel et al. 2004). 
ISCR4 was associated with the MBL gene blaSPM-1, found on a large plasmid in 
various strains of P. aeruginosa, capable of hydrolyzing all β-lactam antibiotics 
except from aztreonam (Murphy et al. 2003; Toleman et al. 2002; Toleman et al. 
2006b). ISCR5 is to date uniquely associated with the class D oxacillinase gene 
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blaOXA-45, found in a P. aeruginosa strain 07-406, which was collected via the 
SENTRY Antimicrobial Surveillance Program from the Anderson Medical Center in 
Texas (Toleman et al. 2006b). ISCR6 was found in six epidemiologically unrelated 
clinical strains of P. aeruginosa that were isolated between 1992 and 1998 in 
Bulgaria. In these strains, ISCR6 is adjacent to an  aminoglycoside 4'-O-
adenylyltransferase encoded by the ant(4’)-IIb gene, conferring resistance to 
amikacin but not to netilmicin (Sabtcheva et al. 2003; Toleman et al. 2006b). 
ISCR7 and ISCR8 were identified by sequences that appear to be incomplete. 
Both were found in Pseudomonas spp., close to genes encoding degradative 
enzymes involved with catabolism of haloalkanes and monocyclic nitroaromatic 
compounds respectively. Both putative transposase genes appear to have 
suffered a deletion and sustained double insertions, in comparison to other ISCR 
genes, suggesting that both transposases are inactive (Toleman et al. 2006b). 
ISCR9 and ISCR10 were discovered in strains of S. maltophilia (Toleman et al. 
2006b). ISCR11 was discovered in two A. baumannii isolates from Germany that 
have the MBL blaVIM-2 and in a P. aeruginosa isolate from Greece that produces 
MBL blaVIM-1 (Toleman et al. 2006b). ISCR12 was found in a P. aeruginosa strain 
that produces the MBL SPM-1 and carries two ISCR elements, ISCR4 and 
ISCR12 (Toleman et al. 2006b). ISCR13 was identified in the A. hydrophila 
genome and displays approximately 54% nucleotide identity to ISCR5. ISCR13 
was found adjacent to a gene with high identity to an aminoglycoside resistance 
gene (Toleman et al. 2006b). 
 
 
1.6 Scope 
 
Antibiotic resistance has become dramatic worldwide, specially in the vast majority 
of the hospitals. Until recently, within the hospital context, species posing 
problems for the treatment of patients were relatively well known. However, 
nowadays any species can be a potential problem if under the favorable selective 
pressures and/or when infecting immunocompromized patients.  
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Moreover, the antibiotic resistance has breached outside of the hospital 
environment due to an inappropriate use of antibiotics. The consequences of this 
misuse, mostly in the veterinary, is not yet very clear but apparently, as it 
happened in the hospital environment, it seems that soon it will be catastrophic. 
The mechanisms involved in the antibiotic resistance are many and in constant 
adaptation to the pressures exerted from the surrounding environment. A special 
attention must be given to the factors potentiating horizontal gene transfer (HGT) 
as the consequences of the transferred resistance are less predictable.  
 
An accurate and detailed study of the prevalent resistance determinants, either 
being resistance genes or structures enhancing/involved in their dissemination is 
needed in order to provide a more realistic scenario. This knowledge will be helpful 
to the clinicians and also to the infection control commissions to implement new 
measures. Therefore all the information gathered in research laboratories is of the 
utmost importance and should be taken into consideration by the clinicians 
whenever it is possible. 
 
 
1.6.1 Main goal of this thesis   
The main goal of this thesis is to contribute to the knowledge of ISCRs distribution 
and prevalence in selected species collected within the hospital environment. 
Microoganisms were isolated from samples, collected at Hospital Infante D. Pedro, 
EPE in Aveiro. The study focuses on the association of ISCRs with antibiotic 
resistance genes, in resistant and MDR isolates. Since, natural environments are 
also important reservoirs of antibiotic resistance genes (Baquero et al. 2008b) 
environmental microorganisms (Gram-negative isolates) were also collected (from 
water and fish guts samples) and screened for the presence of the ISCR 
elements. 
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The thesis is divided in five chapters as follows: 
 
 In chapter 1, 210 non-biased Escherichia coli recovered from three 
separate patient-cohorts in the Hospital Infante D. Pedro, EPE: day care (DC), 
emergency room (ER), and long term inpatients (IP) were studied. These isolates 
were collected from various clinical specimens and their resistance profile was 
determined. The occurrence of ISCR1 elements, integrons and β-lactamase genes 
was also studied.  
 
 In chapter 2, a Klebsiella pneumoniae population collected in 2007 from 
various clinical specimens of inpatients of the Hospital Infante D. Pedro EPE was 
studied. The resistance profile of these isolates was determined and the 
occurrence of ISCRs and resistance genes associated with them was investigated. 
 
Chapter 3, describes a MDR Citrobacter freundii collected in 2008 and 
recovered from an inpatient in the Hospital Infante D. Pedro EPE. The resistance 
profile of this isolate was determined and the occurrence ISCR1 elements, 
integrons and β-lactamase genes was investigated. 
 
In chapter 4, MDR Acinetobacter baumannii isolates were screened for the 
presence of ISCR elements and their genetic context studied. The microorganisms 
were recovered during an outbreak, in 2006, from various biological products of 
inpatients from the Hospital Infante D. Pedro. For comparative purposes, an 
Argentinean population, known to possess the ISCR2 element, was included. 
  
 Chapter 5 aimed to show from an environmental perspective the 
occurrence and dissemination of ISCRs in environmental bacteria. For that 
purpose, microorganisms were collected from geographical distant locations (Ria 
de Aveiro, Portugal and Cardiff lakes, UK) and also from different sources (Water 
and fish guts). 
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2. Material and Methods 
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2.1 Bacterial strains  
 
The clinical isolates used in this study were collected, in different timeframes, from 
various clinical specimens (urine, pus, sputum, blood and others) from patients of 
the Hospital Infante D. Pedro EPE, Aveiro, Portugal. The microorganisms studied 
include: E. coli, K. pneumoniae, A. baumannii and C. freundii. 
 
For comparative studies, Libyan and Argentinean clinical isolates available at Prof. 
Timothy R. Walsh laboratory, Dept. Medical Microbiology, Cardiff University, Heath 
Park, UK, were included. 
 
For the screening of mobile genetic elements in environmental microorganisms, 
isolates were collected from: 
a) Fish guts (Liza aurata): the animals were captured from three different sampling 
sites with different levels and sources of contamination. The sites were S. Jacinto, 
(a clean reference site), Largo do Laranjo (heavy metals contamination) and 
Vagos (agriculture and aquacultures). The guts were recovered from fifteen 
animals and placed in a 50 mL tube with 25 mL of Tryptic Soy broth (TSB, Merck, 
Germany) overnight at 37 ºC. 100 µL of the samples were spread in Gram-
negative selective medium plates, Mackonkey agar (Mck, Merck, Germany) and 
incubated overnight at 37 ºC. Colonies with distinct morphology were selected, 
purified on plates containing the same medium and stored at -80 ºC in microtubes 
with 400 µL of TSB and 200 µL glycerol at 40%. 
b) Water: isolates were kindly provided by Prof. António Correia, Laboratory of 
Microbiology (Microlab), University of Aveiro, Portugal. 
 
Positive controls used in the present study were kindly supplied by Beatrice 
Berçot, Centre Hospitalier de Bicêtre, Service de Bactériologie-Virologie-
Parasitologie-Hygiène, Le Kremlin-Bicêtre, France and Prof. Gabriela Jorge da 
Silva, Faculdade de Farmácia da Universidade de Coimbra, Coimbra, Portugal. 
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2.2 Antibiotics stock solutions  
 
1. Chloramphenicol: 30 mg/mL dissolved in 70% ethanol and stored at -20 ºC. 
 
2. Nalidixic acid: 30 mg/mL in 300 mM NaOH and stored in aliquots at -20 ºC. 
Ciprofloxacin: 2 mg/mL infusion (Claris Lifesciences, UK) 
 
3. Sulphamethoxazol: 30 mg/mL in 0.1 M NaOH, filter sterilised and stored in 
aliquots at -20 ºC. 
  
4. Ampicillin: 100 mg/mL dissolved in distilled water, filter sterilised and stored in 
aliquots at -20 ºC. 
 
4. Sodium azide: 200 mg/mL dissolved in distilled water and stored at -20 °C. 
 
 
2.3 Polymerase Chain Reaction (PCR) amplifications  
PCR reactions were performed using heat-denatured cells from pure cultures or 
DNA as substrate. 20 µL reaction mixtures contained at a final concentration: 1X 
PCR buffer, 3 mM MgCl2, 5% dimethylsulfoxide, 200 µM each nucleotide, 
0.3 pmol/µL of each primer, 1 U of Taq polymerase, and 1 µL of heat-denatured 
cells or 50 -100 ng of purified DNA.  
Different PCR annealing temperatures (Table 2) were used according the gene to 
amplify, but based on the general program described below and during 30 cycles: 
 
Initial Denaturation    95 ºC for 10 min 
Denaturation    95 ºC for 1 min 
Annealing     Variable  1 min 
Elongation      68 ºC for 2 min 
Extension      68 ºC for 5 min 
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Table 2 – Gene, primers sequence, annealing temperature and size of the expected 
fragments 
Gene  Primers sequence (5’-3’)     Annealing       Size (bp)  Reference  
blaTEM  F-AAAGATGCTGAAGATCA   44 ºC  425 (Speldooren et al. 1998) 
  R-TTTGGTATGGCTTCATTC 
blaSHV  F-GCGAAAGCCAGCTGTCGGGC   62 ºC  304 (Henriques et al. 2006) 
  R-GATTGGCGGCGCTGTTATCGC 
blaCTX-M-15 F-AGAATAAGGAATCCCATGGTT  55 ºC  538 (Mendonça et al. 2006) 
  R-ACCGTCGGTGACGATTTTAG 
blaIMP  F-GAATAGAGTGGATTAATTCTC  55 ºC  232 (Henriques et al. 2006) 
  R-GGTTTAAYAAAACAACCACC 
blaVIM  F-GATGGTGTTTGGTCGCATATCG  58 ºC  475 (Henriques et al. 2006) 
  R-GCCACGTTCCCCGCAGACG 
blaOXA 
1
 F-ACACAATACATATCAACTTCGC  53 ºC  814 (Ouellette et al. 1987) 
  R-AGTGTGTTTAGAATGGTGATC 
blaOXA-23 F-GGAATTCCATGAATAAATATTTTACTTGC 55 ºC  840 (Heritier et al. 2005) 
  R-CGGGATCCCGTTAAATAATATTCAGGTC 
blaOXA-40  F-GGAATTCCATGAAAAAATTTATACTTCC 55 ºC  846 (Heritier et al. 2005) 
                 R-CGGGATCCCGTTAAATGATTCCAAGATTTTCTAGC 
int1  F-CTGGATTTCGATCACGGCACG  65 ºC  500 (Barlow et al. 2004) 
  R-ACATGCGTGTAAATCATCGTCG 
VR2  F-GAACCTTGACCGAACGCAG  59 ºC             Variable (Barlow et al. 2004) 
  R-AGCTTAGTAAAGCCCTCGCTAG 
ISEcp13 F-AAAAATGATTGAAAGGTGGT  55 ºC  1200 (Eckert et al. 2004a) 
ISaba1 F-ATGCAGCGCTTCTTTGCAGG  55 ºC  389 (Héritier et al. 2006) 
  R-AATGATTGGTGACAATGAAG 
qnrA  F-GGGTATGGATATTATTGATAAAG  55 ºC  660 (Cattoir et al. 2007) 
  R-CTAATCCGGCAGCACTATTA 
qnrB   F-GATCGTGAAAGCCAGAAAGG  60 ºC  469 (Robicsek et al. 2006) 
  R-ACGATGCCTGGTAGTTGTCC 
qnrS  F-AGTGATCTCACCTTCACCGC  60 ºC  550 (Cattoir et al. 2007) 
  R-CAGGCTGCAATTTTGATACC 
ISCR1 F-GGAGTGACGGGCACTGGCTG  55 ºC  750    This study 
  R-CACTCGTTTACCGCTCAAGC 
ISCR2 F-CACTGGCTGGCAATGTCTAGC  55 ºC  1800  This study 
  R-GAGTCAACTGCGGTCCAAAGC 
floR  F-TCGACATCCTCGCTTCACTG  55 ºC  1200  This study 
  R-ACCTCGTGAATGTCGGTATCC 
sul2   F-TCTTTCAGCGCCGCCAATAC  55 ºC  800    This study 
  R-GACAGTTTCTCCGATGGAGG 
glmM  F-GAGTCAACTGCGGTCCAAAGC  55 ºC  250    This study 
  R-GGCTTTGCCACGAATACCGTCT 
TNIC4  R-CGATCTCTGCGAAGAACTCG  55 ºC  Variable (Toleman et al. 2007b) 
MOX  F-GCTGCTCAAGGAGCACAGGAT  64 ºC      520(Perez-Perez and Hanson 2002) 
  R-CACATTGACATAGGTGTGGTGC 
FOX  F-AACATGGGGTATCAGGGAGATG   64 ºC      190(Perez-Perez and Hanson 2002) 
  R-CAA AGCGCGTAACCGGATTGG 
CMY  F-TGGCCAGAACTGACAGGCAA  64 ºC      462(Perez-Perez and Hanson 2002) 
  R-TTTCTCCTGAACGTGGCTGGC 
ACC  F-AACAGCCTCAGCAGCCGGTTA  64 ºC      346(Perez-Perez and Hanson 2002) 
  R-TTCGCCGCAATCATCCCTAGC 
DHA  F-AACTTTCACAGGTGTGCTGGGT  64 ºC      405(Perez-Perez and Hanson 2002) 
  R-CCGTACGCATACTGGCTTTGC 
1 blaOXA-1 derivates; 
2 VR – Variable region; 3 Primer to be used in combination with blaCTX-M-15 reverse primer 
4 Primer to be used in combination with forward primer of VR 
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All PCRs were carried out with Taq polymerase, nucleotides and buffers 
purchased from ABgene (NewEngland Biolabs, UK) in a Bio-Rad cycler Thermal 
Cycler (Bio-Rad Laboratories, Richmond, CA, USA). PCR products were 
separated by electrophoresis in a 1% agarose gel and stained with ethidium 
bromide (0.5 µg/mL). Gel images were acquired using a Molecular Imager FXTM 
system (Bio-Rad, Richmond, CA, USA) 
 
 
2.4 Nucleotide sequence determination and sequence 
analysis  
PCR products were purified with the Qiagen Agarose Gel Extraction Kit (Qiagen, 
Germany) according to the manufactures instructions and sequenced in both 
strands by STABVida, Portugal. Sequences were edited manually after 
examination of the corresponding chromatogram files using the Biological 
Sequence Alignment Editor Bioedit, version 7.0.0. Similarity to sequences 
deposited in the EMBL Genbank was searched using the BLAST program 
(Altschul et al. 1997). The alignment of the sequences was performed using the 
ClustalW program.  
 
 
 
2.5 Plasmid DNA Extraction  
Bacterial cells were grown overnight in liquid medium, tryptic soy broth (TSB, 
Merck, Germany). Plasmid DNA was extracted with two different protocols: Qiagen 
protocol and alkaline lysis. Protocols were performed as follows: 
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2.5.1 Qiagen protocol 
 
1. 5 mL (or 1 mL) of bacterial culture were centrifuged at 16000 x g. 
2. Cells were resuspended in 250 µL of P1. 
3. 250 µL of P2 were added and the microtubes inverted 4-6 times1.  
4. 300 µL of N3 were added and the solution mixed immediately and 
thoroughly by inverting the microtube 4-6 times2.  
5. The microtubes were centrifuged at 16000 x g. 
6. The supernatant was applied to the spin columns and centrifuged for 60 s 
at 16000 x g. 
7. The columns were washed by adding 500 µL of PB and centrifuged for 
60 s. The flow-through was then discarded. 
8. The spin columns were washed with 750 µL of PE and centrifuged for 60 s 
at 16000 x g. 
9. The flow-through was discarded and the columns centrifuged for 1 min at 
16000 x g.  
10. The DNA was eluted in 50 µL of elution buffer. 
1.The solution needs to become viscous; 2. The solution should become cloudy.   
 
 
2.5.2 Alkaline lysis 
 
1. Bacterial cells were grown overnight in TSB medium (100 mL) at 37 ºC. 
2. Cultures were centrifuged at 16000 x g. 
3. The precipitate was resuspended in 3 mL of solution I1. Lysozyme (25 
mg/mL) was added to solution I. 
4. The precipitate was transferred to a smaller tube and left 15 min at room 
temperature. 
5. 8 mL of solution II2 were added to each tube. The top was covered with film 
and the tube slowly inverted several times and left on ice for 10 min. 
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6. 6 mL of potassium acetate 5 M, pH 4.8 were added. The top was again 
covered and the tube inverted. The tubes were left 10 min on ice. 
7. The solutions were centrifuged at 16000 x g for 30 min at 4 ºC. 
8. Six volumes (vol) of isopropanol were added to each tube, mixed and left 
15 min at room temperature. 
9. The tubes were centrifuged at 8000 x g for 30 min at room temperature. 
10. The supernatant was discarded and the precipitate was resuspended with 
70% ethanol at room temperature. 
11. The tubes were centrifuged 10 min at 8000 x g. The ethanol was discarded 
and the precipitate dried.  
12. The precipitate was dissolved in 1 mL of TE3 buffer containing RNase 
10 mg/mL and left for 1 h at 37 ºC. 
13. An equal volume of chloroform/isoamyl alcohol (24:1) (CIA) was added. 
14. The microtubes were gently mixed for 30 min and centrifuged at 6000 x g 
for 30 min at room temperature. 
15. The supernatant was transferred to a new tube. 
16. 0.6 vol of isopropanol were added and gently mixed allowing for the DNA to 
precipitate for 15 min at room temperature. 
17. The DNA was recovered by centrifugation at 12000 x g for 30 min at 4 ºC.  
18. DNA precipitate was resuspended in 1 mL TE and transferred to a clean 
tube and washed with 1 mL of 70% ethanol. 
19. The microtubes were centrifuged 5min at 16000 x g and the ethanol 
discarded, followed by incubation for 20 min to evaporate the remains of 
ethanol. 
20. 1 mL of TE was added and the DNA dissolved (gently heated if necessary). 
21. An equal volume of Phenol:CIA (1:1) was added. The tubes were gently 
mixed and centrifuged 5 min at 16000 x g. 
22. The upper layer was transferred to a new microtube and an equal volume of 
CIA was added. The microtubes were centrifuged 5 min at 16000 x g. 
23. The upper layer was transferred to a new microtube. 1/10 of NaAc, pH 5.2 
and 2.5 volumes of cold absolute ethanol were added to the transferred 
volume.  
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24. DNA was left to precipitate 16-18 h at -20 ºC and centrifuged 30 min at 
16000 x g at 4ºC. 
25. The precipitate was washed with 70% ethanol and centrifuged 5 min at 
16000 x g. 
26. The precipitate was dissolved in 200 µL of TE. 
27. DNA presence was confirmed by loading 10 µL of DNA in a 1% agarose gel 
and stained with ethidium bromide (0.5 µg/mL). 
1 Solution I: 50 mM Glucose, 25 mM Tris-HCl, 10 mM EDTA; 2 Solution II: 0.2 N NaOH, 1% SDS, H2O to a 
final volume of 100 mL; 3 TE: 10 mM Tris-HCl, pH 7.5, 1 mM EDTA 
 
2.6 Introduction of DNA in E. coli  
2.6.1 Transformation  
For transformation procedures, E. coli TOP10 competent cells (Invitrogen, 
Carlsbad, California, USA) were used and the protocol was performed as follows: 
a) Preparation of competent cells: 
1. TOP10 bacterial cells were grown overnight at 37 ºC in Luria-Bertani broth 
(LB, Merck, Germany). 
2. 1 mL of the culture was centrifuged at 16000 x g for 3 min. 
3. The precipitate was washed 3 times with 1 mL of sterile water. 
4. The precipitate was ressuspended in 80 µL of sterile water. 
b) Transformation protocol: 
1. The cloning product was added1 to competent cells.  
2. The cells were electroporated using the program Ec3, 1 pulse, in a Bio-Rad 
Gene Pulser II electroporator (Bio-Rad, Richmond, CA, USA). 
3. 500 µL of LB broth (LB, Merck, Germany) were immediately added to the 
Gene Pulser® cuvette (Bio-Rad, Richmond, CA, USA) and the suspension 
was transferred to a microtube.  
4. The microtube was incubated in a shaker at 37 ºC for at least 1 h. 
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5. The cells were plated on LB agar medium (LB agar, Merck, Germany) with 
the respective selective marker(s)2. 
1Cloning product: 100 ng of Plasmid DNA; 2Selective marker (s): nalidixic acid 8 µg/mL, ampicilin 
100 µg/mL, ciprofloxacin 0,125 µg/mL, sulphamethoxazole 100 µg/mL. 
 
 
2.6.2 Conjugation 
 
For conjugation procedures, E. coli J53AZr was used as recipient strain and the 
protocol was performed as follows: 
1. Bacterial cells (donor and recipient strains) were grown overnight at 37 ºC 
in Luria-Bertani broth (LB, Merck, Germany). 
2. 1 µL loop was plated in Tryptic Soy Agar (TSA, Merck, Germany) to verify 
the purity of the strain. 
3. The donor and the recipient strains were plated on LB agar medium (LB 
agar, Merck, Germany) in a 5:1 ratio with the respective selective 
marker(s)1 and left for 18 h at 37 ºC.  
4. The transconjugants were selected and the resistance transfer verified. 
1Selective marker (s): nalidixic acid 8 µg/mL, ampicilin 100 µg/mL, ciprofloxacin 0,125 µg/mL, 
sulphamethozaxol 100 µg/mL. 
 
 
2.7 DNA hybridisation  
2.7.1 Labeling of DNA probes – Radio labeling and DIG labeling 
 
Radio labeling  
 
DNA fragments to be used as probes were labeled with [α-32P]-α-CTP by random 
primer extension using a commercially available kit (Stratagene, UK) according to 
the manufacturer’s instructions.  
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1. 15 µL of DNA1, 8 µL of DNase-free water and 10 µL of primers, were mixed 
together in a screw-top microtube and boiled for 5 min.  
1. Note: Buffer dCTP was used. 
2. 10 µL of Buffer, 2.5 µL of 32P and 1 µL of Klenow, were quickly added to the 
microtube to keep temperature hot. The microtube tube was placed in a 
lead jar at 37 °C for 15 min. 
3. Unincorporated nucleotides were removed by passing the labeled DNA 
through a Sephadex column (Nick column, Pharmacia Bio-tech, Uppsala, 
Sweden). 320 µL of 0.1 M Tris-HCl buffer, pH 7.5, were added and moved 
to a collection tube. 430 µL of Tris-HCl buffer were added and the run-
through collected. 
4. The collected run-through was boiled for 6 min and added to the gel in the 
hybridisation tube and incubated for 3-5 h or overnight.  
       1 
50 -100 ng of purified DNA 
 
 
 
DIG labeling of a PCR product 
 
1. 5 µL of PCR product1 were added to 11 µL of H2O. 
2. The microtube was placed in boiling water for 10 min. 
3. The microtube was then immediately placed on ice for 5 min. 
4. 4 µL of Dig-High Prime (Roche Molecular Biochemicals, Indianapolis, USA) 
were added and gently shaken. 
5. After a short spin, the reaction was incubated overnight (16-20 h) at 37 ºC. 
6. The microtube was incubated at 65 ºC for 10 min to stop the reaction. 
7. The reaction was stored at -20 ºC until further use.  
        1 
1 - 50 ng of DNA 
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2.7.2 Hybridisation of Pulse Field Gel Electrophoresis gels 
 
The hybridisation was used for the location of the genes of interest. This method 
was applied to Pulse Field Gel Electrophoresis gels (See section 2.11) . 
1. The gel was placed on a sheet of filter paper and left at 50 °C at least 
overnight. 
2. The gel was then soaked in water for at least 45 min or until fully hydrated 
and placed in denaturing solution1 for 45 min and then transferred to 
neutralising solution2 for 45 min. 
3. The gel was placed in the hybridisation tube and 20 mL of pre-hybridisation 
solution3 were added. 
4. The tube was placed into the hybridisation oven at 65 °C overnight and the 
labeled probe was added. 
5. After 16-18 h tube content was removed and the gel wrapped in cellophane, 
covered with a Kodak XRP-1 film and stored at -80 ºC for 2 days. 
6. The film was developed 1-5 min in Kodak GBX developer, rinsed in distilled 
water for 30 sec and fixed in Kodak GBX fixer for 5 min. The film was rinsed 
again in distilled water for 30 sec and air-dried. 
1Denaturing solution: 1.5 M NaCl; 0.5 M NaOH; 2Neutralising solution: 1.5 M NaCl, 0.5 M Tris-
HCl, pH 7.2, 1 mM EDTA. 3Pre-hybridisation solution: 6 mL 20xSSC (3 M NaCl, 0.3 M Sodium 
Citrate, pH 7.0), 5X Denhardt's solution (0.1% (w/v) polyvinylpyrrolidone, 0.1% (w/v) ficoll type 
400, 0.1% (w/v) bovine serum albumin), 300 µL of denaturated salmon sperm DNA (100 
mg/mL) and water up to a final volume of 20 mL.  
 
 
2.7.3 Colony Blot  
 
The colony blot technique was used to detect the presence of the genes of 
interest. The method was performed as follows: 
 
1. Colonies to be screened were “tooth-picked” on to media, with a positive 
and negative control colony and incubated overnight at 37 ºC. 
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2. The colonies were transferred to a positively charged nylon membrane 
(Amersham HybondTM-N+, GE Healthcare, UK).  
3. The membrane was placed colony side up on a Whatmann 3MM filter, 
presoaked for 5 min with 5% SDS. 
4. The excess moisture was removed, onto Whatmann 3MM paper. 
5. The filter was placed onto a Whatmann 3MM paper presoaked with 
denaturing solution1 for 5 min. 
6. The excess of moisture was removed and the filters placed carefully floating 
colony side up on neutralising solution2 for 5 min. 
7. After 5 min, the filter was submerged in the neutralising solution and the 
cellular debris was carefully washed from the filter.  
8. The excess of moisture was removed onto Whatmann 3MM paper. 
9. The filter was submerged in 6X SSC solution for 5 min and then the excess 
of moisture was removed onto Whatmann 3MM paper. 
10. The DNA was fixed to the membrane by incubation at 80 ºC for at least 2 h. 
11. The membranes were pre-hybridized with pre-hybridisation solution3 at 
65 ºC for 2 h and the probe was then added and left overnight (16-18 h). 
12. The membranes were washed with 2X SSC for 30 min at 65 ºC and 1X 
SSC for 30 min at 65 ºC, wrapped in cellophane, covered with a Kodak 
XRP-1 film and stored at -80 ºC for 2 days. 
13. The film was developed 1-5 min in Kodak GBX developer, rinsed in distilled 
water for 30 sec and fixed in Kodak GBX fixer for 5 min. The film was rinsed 
again in distilled water for 30 sec and air-dried. 
1 Denaturing solution: 1.5 M NaCl; 0.5 M NaOH; 2Neutralising solution: 1.5 M NaCl, 0.5 M Tris-HCl, 
pH 7.2, 1 mM EDTA. 3Pre-hybridisation solution: 6 mL 20xSSC (3 M NaCl, 0.3 M Sodium Citrate, 
pH 7.0), 5X Denhardt's solution (0.1% (w/v) polyvinylpyrrolidone, 0.1% (w/v) ficoll type 400, 0.1% 
(w/v) bovine serum albumin), 300 µL of denaturated salmon sperm DNA (100 mg/mL) and water up 
to a final volume of 20 mL.  
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2.8 Capture of DNA using Dynabeads M-280 Streptavidin 
system 
 
To determine flanking sequences of a gene in the genome, a two-step PCR 
reaction technique can be applied using a biotinylated primer plus degenerate 
primers for amplification. Amplified biotinylated DNA fragments were isolated with 
a Dynabeads M-280 Streptavidin system (Sorensen et al. 1993). All PCR reactions 
were carried out using the PCR protocol outlined in section 2.3 but 42 cycles were 
employed for the first amplification. Genomic DNA was used as template in the 
first PCR reaction, whereas an aliquot from the first PCR reaction was used as a 
DNA template for the second PCR reaction. 
 
 
1. PCR reactions with biotinylated primers designed for the target gene (Primer Rv 
and Fw) and random primers (R1, R2, R3, R4) were performed to a final volume of 
50 µL as follows: 
 
PCR mastermix 25µL  25µL  25 µL   25µL 
Primer Rv or Fw 1µL  1µL  1µL  1µL 
R1   1µL  -  -  - 
R2   -  1µL  -  - 
R3   -  -  1µL  - 
R4   -  -  -  1µL 
DNA   1µL  1µL  1µL  1µL 
H2O   22µL  22µL  22µL            22µL 
PCR mastermix contained: 1X PCR buffer, 3 mM MgCl2, 5% dimethylsulfoxide, 200 µM each 
nucleotide, 0.3 pmol/µL of each primer, 1 U of Taq polymerase, and 1 µL of heat-denatured cells or 
50 -100 ng of purified DNA.  
 
2. PCR amplifications were performed using the following program: 
 
Initial Denaturation    95 ºC for 10 min 
Denaturation    95 ºC for 1 min 
Annealing     45 ºC for 1 min 
Elongation      68 ºC for 1 min 
Extension      68 ºC for 5 min 
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3. The dynabeads were washed three times with 2X wash buffer (TE).  
 
Note: Beads stock was at 10 mg/mL. 200 µg of beads per reaction were needed and were 
ressuspended in twice of the initial volume. 
 
4. 40 µL of PCR product were mixed with 40 µL of Dynabeads (containing 200 µg) 
and incubated for a minimum of 15 min at room temperature. 
5. The beads were washed with 1X wash buffer and resuspended in 10 µL of 1X 
wash buffer. 
6. 5 µL of beads were used for the next PCR reaction with flanking primers (NF 
primer). 
 
 
PCR mastermix 25µL  25µL  25 µL   25µL 
Primer Rv or Fw 1µL  1µL  1µL  1µL 
NF primer  1µL  1µL  1µL  1µL  
Beads  5µL  5µL  5µL  5µL 
H2O   18µL  18µL  18µL            18µL 
PCR mastermix contained: 1X PCR buffer, 3 mM MgCl2, 5% dimethylsulfoxide, 200 µM each 
nucleotide, 0.3 pmol/µL of each primer, 1 U of Taq polymerase, and 1 µL of heat-denatured cells or 
50 -100 ng of purified DNA.  
 
7. PCR amplifications were performed using the program described below: 
 
Initial Denaturation    95 ºC for 10 min 
Denaturation    95 ºC for 1 min 
Annealing     58 ºC for 1 min 
Elongation      68 ºC for 2 min 
Extension      68 ºC for 5 min 
 
 
8. PCR products were separated by electrophoresis in a 1% agarose gel in 1X 
TBE buffer (TBE Buffer 10X: 0.89 M Tris Borate pH 8.3).  
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2.9 DNA Digestion 
 
DNA was digested with restriction endonucleases as follows: 
DNA       200-1000 ng 
10X enzyme buffer     1 µL 
Restriction enzyme      1 µL 
Sterile, distilled water was added to a final volume of 10 µL and the reaction was 
incubated at enzymes respective temperature. 
When restricted DNA was to be visualized on an agarose gel without further treatment, the reaction 
was terminated by the addition of 3 µL stop mix (40% (w/v) sucrose, 0.2M EDTA pH 8.0 and 0.15% 
(w/v) bromophenol blue). Otherwise reactions were terminated using a phenol chloroform wash or 
by heating at the appropriate temperature for 10 min 
 
Where partial digestions were required, preliminary reactions were performed in 
order to determine optimal reaction conditions. Serial dilutions of the enzymes 
were prepared and samples were withdrawn at set time intervals and the products 
analysed by agarose gel electrophoresis. The restriction was then repeated using 
those conditions that produced the desired partial digestion, in the preliminary 
reaction.  
 
2.10 DNA Ligation  
Ligation of DNA was performed with T4 DNA ligase in a final reaction volume of 
10 µL. For subcloning experiments, a 3:1 molar ratio of insert DNA to vector was 
used. Ligation reactions were incubated overnight at 20 ºC. The ligation mix was 
heated at 70 ºC for 10 min and micro-dialysed on filter discs (0.025 µm pore; 
Milipore, UK) for 30 min prior to electroporation.  
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2.11 Pulse Field Gel Electrophoresis (PFGE) 
Pulse field gel electrophoresis was used to acess gene location and bacterial 
typing. 
1. Strains were grown overnight on agar plates at 37 ºC. 
2. A 10 µL loop of cells suspended in 3 mL of saline were harvested in a bijou 
tube. 
3. The OD(Abs:600nm) of each strain was measured. The volume of cells was 
adjusted to the equivalent of 300 µL at OD(Abs:600nm) of 1.5 following the 
formula: 1.5/measured OD x 300 µL.  
4. The cells were centrifuged at 16000 x g for 30 sec and the supernatant was 
removed.  
5. The cells were resuspended in 300 µL of normal saline and placed in a dry 
block at 50 ºC. 
6. 2-3 drops of lysozyme at the concentration 25 mg/mL were added, 
immediately followed by 300 µL of pre-warmed (50 ºC) 2% low melting point 
agarose (Sigma, Germany) and gently mixed with a pipette. 
7. The mix was quickly loaded into the PFGE plug moulds and after 15-20 min 
setting time, the plugs were removed from the plug moulds and each set of 
5 placed in 2 mL of lysis buffer1 in an individual well of a 24 well plate. The 
lysis buffer was supplemented with 80 µL of lysozyme (25 mg/mL) per well 
and incubated for 1.5 h at 37 ºC. 
8. The plugs were washed with 2 mL of 1X TE buffer for 30 min at 37 ºC. 
9. The TE buffer was removed and replaced by 2 mL of proteolysis buffer2 
containing 20 µL of 10 mg/mL Proteinase K. 
10. The plugs were incubated at 50 ºC for 18 h. 
11. After this the plugs were washed 5X30 min in 1X TE buffer. At this stage 
the plugs can be stored for 3-6 months. Plug digestion is carried out in 
individual wells of a 48 well plate. Up to 2 plugs can be digested in a single 
well. 
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S1 digestion of agarose plugs: 
1. The plugs were washed in 1:10 TE buffer with gentle shaking for 30 min at 
room temperature.  
2. The plugs were then washed 15 min with 1X S1 buffer or left overnight at 
4 ºC. 
3. The buffer was then removed and 1 µL of 1:4000 S1 enzyme (NewEngland 
Biolabs, UK) was added directly to the plug. The plugs were incubated at 
37 ºC for 45 min precisely. The digestion is stopped by adding 100 µL of ES 
buffer for 5 min at 4ºC.  
4. The plug was suspended in TE buffer and loaded onto the gel.  
 
SmaI digestion of agarose plugs: 
1. The plugs were washed in 1:10 TE buffer with gentle shaking for 30 min at 
room temperature.  
2. The plugs were then washed and left overnight at 4 ºC with 1X SmaI buffer.  
3. The buffer was then removed and 1 µL of SmaI enzyme (NewEngland 
Biolabs, UK) was added directly to the plug. The plugs were incubated at 
37 ºC for 3 h. 
4. The plug was suspended in TE buffer and loaded onto the gel.  
 
Agarose gel and electrophoresis conditions: 
1. A 1% agarose gel was prepared in 0.5% TBE buffer and 20 µL ethidium 
bromide (0.5 µg/mL) were added. 
2. The gel was removed from the tray and placed in the electrophoresis tank 
previously washed with 70% ethanol. 
3. The DNA was separated in the Chef DR111 System (Bio-Rad, Richmond, 
CA USA) with the following conditions: Bio-Rad Cooling module was set at 
14 ºC, an initial pulse 5.0, final pulse 45.0, running time 20 h, 6.0 volts and 
an angle 120.  
1Lysis buffer: 10 mM Tris-HCl, pH 7.2, 50 mM NaCl, 0.2% sodium deoxycholate, 0.5% N-
lauroylsarcosine; 2Proteolysis Buffer: 100 mM EDTA, pH 8, 0.2% sodium deoxycholate, 1% 
lauroylsarcosine; TE Buffer 1x: 10 mM Tris-HCl, pH 7.5, 1 mM EDTA; ES Buffer 0.5 M EDTA, pH 8, 
1% N-lauroylsarcosine; TBE Buffer 10x: 0.89 M Tris Borate pH 8.3. 
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3. Chapter 1 – ISCR1 prevalence in Escherichia coli 
clinical isolates 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3.1 Introduction 
 
Escherichia coli, a member of the Enterobacteriaceae family, is the main aerobic 
commensal bacterial species in the bowel flora yet, in the urinary tract or in blood, 
it can become pathogenic. In fact, it is the leading Gram-negative pathogen 
causing nosocomial and community acquired infections. Since E. coli easily 
acquires resistance and is commonly found in many different animal species, its 
antimicrobial resistance profile is well documented worldwide (Erb et al. 2007; von 
Baum and Marre 2005). It is frequently resistant to aminopenicillins, such as 
amoxicillin or ampicillin and narrow-spectrum cephalosporins (Tenover 2006). 
Multiresistant isolates are becoming a common presence within the clinical 
environments, mainly because bacteria have an impressive capacity to acquire 
new genes and to rearrange its genetic information (Toleman et al. 2006b). For 
instance, plasmids started being acquired from environmental bacteria and 
throughout time have been combining with other elements such as transposons, 
integrons, insertion sequences (IS) and more recently with insertion sequence 
common regions, or ISCR elements (Walsh 2006). Most of these elements carry 
antibiotic resistance, whereas other are involved in the mobilization of such genes. 
In E. coli resistance is now becoming addressed to all antibiotic spectrums, for 
instance β-lactam, quinolones, aminoglycosides. The most common mechanism of 
resistance to β-lactam antibiotics is the production of β-lactamases. These 
enzymes are encoded by genes that evolve rapidly, thus constituting a group 
characterized by high levels of molecular diversity. CTX-M β-lactamases are 
plasmid-mediated ESBLs and confer high-level resistance to cefotaxime, 
ceftriaxone and aztreonam and are well inhibited by clavulanate and tazobactam 
(Karim et al. 2001). The blaCTX-M genes encoding these β-lactamases are involved 
in this resistance, with a increasing predominance of blaCTX-M-15 (Eckert et al. 
2004b). The blaCTX-M-15 gene is typically associated with ISEcp1 as part of a 
transposition unit (Walsh 2006). In 2006, Machado et al. investigated the presence 
of ISCR1 in 17 Portuguese ESBL positive clinical isolates; however, ISCR1 could 
not be detected (Machado et al. 2006). Unfortunately, this study was naturally 
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biased and did not reflect the true prevalence of ESBL or antibiotic resistance 
gene carriage. Considering the results obtained by these authors, our aim was to 
evaluate the prevalence and occurrence of ISCR1 elements, integrons and β-
lactamase genes in a non-biased population. For that, 210 non-biased E. coli 
isolates were collected from three separate patient-cohorts: day care (DC), 
emergency room (ER), and long term inpatients (IP) in the hospital Infante D. 
Pedro, EPE, Aveiro.  
 
3.2 Results and Discussion 
3.2.1 Isolates background 
 
A total of 210 E. coli strains were collected from different biological products, 
between May 1st, 2006 and November 30th, 2006 at Hospital Infante D. Pedro, 
EPE, Portugal. The population analysed was non-repetitive and only single 
isolate/patient was included in the study. Species identification was performed with 
VITEK2 Compact and Advanced Expert System (AES) (bioMérieux, Marcy 
L´Étoile, France). Thirty-six isolates were collected from the DC, one hundred and 
twenty four collected from the ER and fifty from IP. Figure 18 shows the range of 
age of the patients from whom the strains were isolated versus the number of 
isolates (1 from each patient) in each interval. As expected, a higher number of 
isolates were retrieved from the elderly (>70) and infants (<1) groups. 
 
 
 
 
 
 
 
 
 
Figure 18 – Patients ages interval is represented in the vertical axis and horizontal axis represents the 
number of patients from whom the E. coli isolates were collected.  
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The isolates were collected from different clinical specimens as shown in Table 3. 
Urine yielded the higher number of isolates in the 3 cohorts. The result was not 
surprising since E. coli is one of the pathogens frequently associated to urinary 
tract infections.  
 
 
3.2.2 Antimicrobial susceptibility testing 
 
Susceptibilities were determined, according to guidelines of CLSI standards (CLSI 
2006). It has been reported that resistance to antibiotics, such as ampicillin and 
tetracycline, may be linked to the time that they are available in the clinical practice 
(White et al. 2001). Thus, in the present study, it was also found that ampicillin 
was the β-lactam where higher levels of resistance (64%) were observed. As 
representative of the carbapenems, meropenem is often a choice for systemic 
infections treatment. However, if until recently reports of carbapenem resistant 
Enterobacteriaceae were rare, now they are becoming frequent, thus 
compromising carbapenems efficacy (Nadkarni et al. 2009; Tokatlidou et al. 2008). 
All isolates analysed were sensitive to meropenem concurring with other studies 
performed in Portugal (Mendonça et al. 2007). Among cephalosporins, first 
generation cephalotin, exhibited higher percentage of resistance (31%) when 
compared with the fourth generation compounds represented by cefepime (11%). 
Twenty-five isolates (12%) were simultaneously resistant to cefotaxime and 
ceftazidime. There was no discernable difference between levofloxacin and 
norfloxacin. Moreover, co-resistance to quinolones and cephalosporins was 
observed in 41 isolates (20%) concurring with the studies by Morosini et al. that 
co-resistance observed is a key factor in the maintenance and dispersion of these 
isolates (Morosini et al. 2006). Since this is a class of antibiotics commonly used to 
treat urinary tract infections, along with β-lactams and macrolides, the increasing 
level of resistance exhibited by an increasing number of isolates tends to render 
them ineffective in the clinical treatment. Resistance observed among the 
aminoglicosides was higher to gentamicin (19%) when compared to amikacin 
_____________________________________________________________________________________________ 
 86 
(1%). Morosini and co-workers (2006) obtained similar results of amikacin efficacy 
in a study with ESBL-producing Enterobacteriaceae isolates. 
 
 
3.2.3 ISCR1 detection by colony blotting  
 
Hybridisation experiments were conducted to evaluate the occurrence of ISCR1 
using the colony blot methodology described in Material and Methods section 
2.7.3.  
 
   
A)      B) 
Figure 19 – A) E. coli isolates grown in MacConkey agar (bioMérieux, France); B) A positive result was 
revealed by autoradiography of the blotted colonies using the ISCR1 probe. Arrows indicate an 
example of a positive result. 
 
 
ISCR1 positive colonies were subsequently confirmed by PCR followed by 
nucleotide sequence confirmation. The amplicons were separated in a 1% 
agarose gel (Figure 20).  
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Figure 20 – ISCR1 amplicons of the E. coli positive colonies, separated in a 1% agarose gel 
electrophoresis. Primers used were previously described in Material and Methods section 2.3; M- 
GeneRuler 100 bp DNA Ladder (MBI Fermentas, Vilnius, Lithuania). 
 
 
The presence of ISCR1 was detected in 42 isolates (20%) (Table 3) which can be 
considered a high occurrence of such mobile genetic determinant. Moreover, they 
were found evenly distributed between DC, ER and IP. All ISCR1 positive strains 
harbored a class 1 integron, which reinforces the linkage between these two 
structures. Interesting the study by Machado et al. reported that no ISCR1 (CR1) 
elements were found from strains in 2005-2006, which suggests that the advent 
and dissemination of ISCR1 is a recent event in Portugal. Accordingly, this is the 
first description of ISCR1 elements in E. coli isolates from Portugal. Interestingly, 
ISCR1 elements were detected in strains with low resistance levels suggesting 
that these bacteria maintain “genetic tool kits” for the acquisition of antibiotic 
resistance genes (Bennett 2008).  
 
 
3.2.4 Class 1 integrons screening 
 
Screening for class 1 integrons was performed in two steps. First the int1 gene 
was screened by PCR and the positives strains were subsequently submitted to a 
new PCR to amplify the corresponding variable regions. Amplification conditions 
and primers were used as described in Material and Methods section 2.3.  
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intI1 gene was detected in 20% of the isolates. A total of 10 gene cassettes 
occurring in 8 different cassette arrays were identified – where the variants of the 
aadA and dfr genes were the most frequently found (Table 3). aadA gene variants 
confer resistance to streptomycin and spectomycin and represent 30% of the total 
gene cassettes found among the isolates. 
Trimethoprim resistance is associated with dfr genes, usually inserted in integrons 
(Machado et al. 2005). In the present study dfr genes represent 50% of the gene 
cassettes detected. However, the presence of class 1 integrons could not be 
detected in all co-trimoxazole resistant isolates (26%). These results may suggest 
that sulphamethoxazole resistance may be due to the presence of other sul genes 
apart from sul1. 
The results obtained in both the β-lactamase genes screening and class 1 integron 
detection suggest that the dissemination of these resistance determinants is a 
worldwide phenomenon. For instance, the array [blaOXA-30 –aadA1] was described 
in 2003 (AY224185) in an E. coli clinical isolate from France. Additionally, the 
array [dfrA17-aadA5] has previously been described in A. baumannii (EF015498), 
Enterobacter cloacae (EF571855) and P. aeruginosa (DQ838665). When 
described in E. coli this array was found in isolates from animal (DQ663488) as 
well as the clinical sector (AB194702 and FJ0011847) and scattered all over the 
world in countries so distant as China, Turkey and the Netherlands. The rapid 
dissemination of these structures between different countries may be explained by 
the society behavior. Nowadays, traveling is easier and faster, leading people to 
act as vehicles to these structures, by transportation of bacteria that carry them, 
from one point to another (Hawkey and Jones 2009).  
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Table 3 – Characterization of E. coli isolates concerning demographic data, 
integrons content and bla genotypes. 
   
Day care 
Emergency 
Room 
Inpatients 
(Nosocomial) 
Total number of isolates 36 124 50 
Range of ages <1 to >70 <1 to >80 3 to >80 
Urine 31 84 33 
Blood 0 18 2 
B
io
lo
g
ic
al
 
P
ro
d
u
ct
s 
Othera) 5 22 15 
intI1 gene 8 (22%) 26 (20%) 8 (16%) 
Putative gene cassettes 
dfrA25 
dfrA12-aadA2 
dfrA17-aadA5 
dfrA1-aadA1 
blaOXA-30 –aadA1 
dfrA1-aadA1 
spec-aadA1 
dfrA4 
dfrA1-aadA1 
aadA1 
ISCR1 8 (22%) 26 (20%) 8 (16%) 
blaTEM-1 17(47%) 99 (80%) 18 (36%) 
blaOXA-30 0 8 (6%) 17 (34%) 
β
-l
a
c
ta
m
a
s
e
 
c
o
n
te
n
t 
 
blaCTX-M-15 5 (14%) 15 (12%) 5 (10%) 
a) Other- Sputum, swab wounds, pus;  
 
 
3.2.4 β-lactamase genes content  
 
A first screening of β-lactamase genes content was performed in the VITEK2 
Compact and AES (BioMérieux, Marcy L´Étoile, France). Additionally, and to 
confirm VITEK2 system results, the presence of β-lactamase genes belonging 
TEM, CTX-M, OXA groups was screened by PCR, and the nucleotide sequence of 
the amplicons was determined. Amplification conditions and primers used were 
previously described in Material and Methods section 2.3.  
PCR based methods are not yet implemented in the routine of the majority of the 
hospitals in the country and Hospital Infante D. Pedro is not an exception. The use 
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of Etest strips is therefore an important tool to be used for the rapid detection of 
ESBL-producing strains. Etest ESBL strips with cefotaxime/ cefotaxime + 
clavulanic acid (CT/CTL), ceftazidime/ ceftazidime + clavulanic acid (TZ/TZL) and 
cefepime/ cefepime + clavulanic acid (PM/PML) were used according to the 
manufacturer’s instructions (AB bioMérieux, Solna, Sweden) to detect ESBL 
production. The comparison between the results obtained from the VITEK2 
Compact and Etest ESBL strips, and further confirmed by PCR, revealed that the 
two methods provided similar results. 43% of the isolates were positive for the 
presence of an ESBL, noteworthy 10% of these were isolated from biological 
products from the Pediatrics ward (inpatients). This result is of foremost concern, 
highlighting the growing number of strains carrying ESBLs in the pediatrics 
population. The spread of resistance determinants such as ESBL poses a major 
problem for the treatment of these patients since only a few of the available 
antibiotics can be used in the pediatric patients, which narrows the treatment 
options. 
PCR results obtained for each β-lactamase gene group tested revealed that blaTEM 
was present in 64% of the isolates studied and both blaCTX-M and blaOXA were 
detected in 12% of the isolates. Nucleotide sequence analysis revealed that all the 
isolates that were positive for the presence of blaTEM, possessed the blaTEM-1 
variant. Moreover, all were ampicillin resistant, suggesting that this gene might be 
responsible for the resistance observed. All the isolates positive for the presence 
of blaCTX-M were resistant to cefotaxime. A study conducted in Spain by Valverde 
and colleagues showed that strains carrying blaCTX-M have a higher tendency to be  
MDR strains, when compared to strains carrying other type of ESBLs (Valverde et 
al. 2004). For instance, strains producing blaCTX-M exhibit higher levels of 
resistance to tetracyclines and ciprofloxacin, when compared to strains producing 
blaTEM-4 and blaSHV-12. In the present study, 75 % of blaCTX-M producing strains were 
also resistant to quinolones and 42% to tetracycline. 
The genetic environment of blaCTX-M genes found among the population being 
studied, was investigated. Nucleotide sequence analysis identified blaCTX-M-15 as 
the variant present in the isolates positive for the presence of this gene. These 
findings are consistent with those reported by other authors, regarding the 
dissemination of blaCTX-M-15 in Portugal, where this gene is the predominant variant 
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(Mendonça et al. 2007). Interestingly, fifteen blaCTX-M-15 positive isolates were 
recovered from the emergency room from patients with no previous clinical 
records, and were thus considered to be from the community background, 
suggesting its presence in other reservoirs as also reported by other authors 
(Mendonça et al. 2007). Several studies worldwide report blaCTX-M dissemination in 
both clinical and community environments, and among different Gram-negative 
species (Prats et al. 2003). Although the isolates positive for the presence of 
blaCTX-M were resistant to cefotaxime, not all cefotaxime resistant isolates (18%) 
possess the blaCTX-M gene. In these cases, the presence of another broad range β-
lactamase should be expected, namely blaDHA-1, a plasmid mediated AmpC with 
hydrolytic activity against third generation cephalosporins (Yan et al. 2002)  
Nucleotide sequence analysis identified blaOXA-30 in strains positive for blaOXA, 
which has a special hydrolytic activity against cloxacillin and also hydrolyzes 
cefepime (Dubois et al. 2003). Thus, the results obtained may explain the 
resistance exhibited by these positive isolates. Nucleotide sequence analysis also 
revealed that blaOXA-30 gene was located within an integrants in eight isolates. The 
genetic location of blaOXA-30 genes in mobile genetic elements such as integrons 
may potentiate their dissemination among other isolates (Dubois et al. 2003). 
 
3.2.5 General Conclusion 
 
The vast majority of the isolates included in this study were isolated from urine and 
from the two cohorts Day Care and Emergency Room. ISCR1 was found evenly 
distributed among Day Care, Emergency Room and inpatients. Integrons were 
detected in the three cohorts. However, seven different arrays were found in 
isolates from Day Care and Emergency Room and only two arrays were detected 
in inpatients. blaTEM was the predominant bla gene in the three cohorts.  
The presence of mobile genetic elements such as the ISCRs in these isolates is 
preoccupant since it can enhance the dissemination of resistance determinants 
under favorable circumstances.  
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4.1 Introduction 
 
Multi-drug resistant (MDR) organisms continue to represent a significant challenge 
in the management of hospitalized patients with infections. Such infections are 
often opportunistic and are associated with hospitalization, and include 
pneumonia, urinary tract and wound infections and neonatal meningitis. 
Organisms such as MDR K. pneumoniae are common nosocomial pathogens 
causing severe morbidity and mortality (Melano et al. 2003). Additionally, 
Klebsiellae survive longer than other enteric bacteria on hands and environmental 
surfaces, facilitating cross-infection within hospitals (Paterson and Bonomo 2005). 
For instance, even prior to the advent of ESBLs, large multiresistance plasmids 
were more common in Klebsiella spp. than in E. coli, contributing to a fast 
dissemination of antibiotic resistance genes. Moreover, most K. pneumoniae 
isolates have a chromosomally encoded SHV-1 β-lactamase (Melano et al. 2003). 
Plasmid-mediated quinolone resistance encoded by qnrA, qnrB or qnrS genes has 
been reported worldwide (Nordmann and Poirel 2005). qnrA, was the first qnr 
gene described in a K. pneumoniae in  by Martinez et al. (1998). Subsequently, it 
has been shown to be widely spread all over the world, as part of a complex sul1-
type integron containing ISCR1(Nordmann and Poirel 2005). qnrB and qnrS have 
also been reported in many countries from Europe, Asia and the United States 
(Nordmann and Poirel 2005). Dissemination of plasmids carrying these genes can 
potentiate the rapid development of higher-level quinolone resistance in bacterial 
strains currently classified as susceptible (Robicsek et al. 2005a). Moreover, 
transferrable qnr genes are usually carried by conjugative plasmids (50 to 180kb) 
that often encode ESBLs or AmpC-type β-lactamases (Lascols et al. 2008). In fact, 
epidemiological studies of the distribution of qnr determinants show that qnr 
positive strains frequently express ESBLs (Garnier et al. 2006). Cephalosporins, 
such as cefotaxime and ceftriaxone, are commonly used to treat Klebsiellae 
infections, however multiple MDR strains may limit the antibiotic choice.  
Herein a MDR K. pneumoniae population, collected from inpatients from the 
Intensive Care Unit was characterized and the occurrence of ISCR1 associated 
with other antibiotic resistance genetic determinants was investigated.  
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4.2 Results and Discussion 
4.2.1 Clinical context of K. pneumoniae recovery 
 
The population of K. pneumoniae collected was constituted by MDR isolates 
associated with infection. The patients infected were hospitalized in the Intensive 
Care Unit (ICU). The isolates were retrieved from different biological products 
including sputum (10 isolates), blood (2 isolates), pus (4 isolates), urine (3 
isolates) and catheter (1 isolate) (Figure 21). As expected, the biological product 
from which a higher number of isolates was collected was the sputum. These 
results may be explained by the fact that the majority of the patients hospitalized in 
this ward are usually diagnosed with respiratory tract infections being K. 
pneumoniae one of the major pathogens associated with it. 
 
 
 
 
 
 
 
 
 
 
Figure 21 – Biological products and number of K. pneumoniae isolates selected for the present study. 
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The ages of the inpatients ranged between 43 and 91 years. The advanced age of 
most of the patients can be critical for the treatment, since the patients 
hospitalized in the ICU are under heavy doses of medication, thus being very 
debilitated and with a compromised immune system. Therefore an infection 
caused by a pathogen such as MDR K. pneumoniae represents an enormous 
threat to the success of the treatment. 
 
 
4.2.2 Antimicrobial susceptibility testing  
 
Susceptibilities were determined, according to guidelines of CLSI standards (CLSI 
2006). Antibiotic susceptibilities were tested to 21 antibiotics belonging to the 
following classes: β-lactams including the penicillins (aminopenicillins, 
carboxypenicillins and ureidopenicillins), cephalosporins (first, second, third and 
fourth generations), monobactams and carbapenems. Additionally, another four 
classes of antibiotics were tested: tetracyclines, fluoroquinolones, 
aminoglycosides, and the combination sulphamethoxazole/trimethoprim.  
In general, the pattern of resistance was very similar among the different isolates. 
Strains that were resistant to at least three different classes of antibiotics were 
considered as MDR. β-lactam, fluoroquinolones and the combination 
sulphametoxazole/trimethoprim were the three different classes of antibiotics, to 
which higher resistance was observed. All the isolates were sensitive to the 
carbapenems, imipenem and meropenem. 
Quinolones resistance profile of the 21 isolates revealed that all of them were 
resistant to nalidixic acid (≥ 32 µg/mL) and the fluoroquinolone ciprofloxacin (≥ 4 
µg/mL). Nineteen isolates were intermediate resistant (8 µg/mL) and two were 
resistant (≥ 16 µg/mL) to norfloxacin (Table 4). These results indicate that the use 
of this class of antibiotics may be seriously compromised in a short-term period. In 
the clinical practice, intermediate resistant isolates to a given antibiotic should be 
reported to the clinician, as resistant isolates. These isolates exhibit in vitro a 
reduced susceptibility to the antibiotic that can easily lead to a resistant phenotype 
in vivo. Therefore, the nineteen strains with reduced susceptibility to fourth 
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generation quinolones should be reported as resistant, alerting the clinicians to a 
vigilant use of this antibiotic. 
 
 
4.2.3 ISCR, β-lactamase genes content and class 1 integrons  
Beta-lactamase genes screening was performed by PCR using the primers and 
conditions described in the Material and Methods section 2.3. The results revealed 
that blaTEM was found in 38% of the isolates and blaSHV in 86%, which may explain 
the resistance to penicillins, namely to ampicillin, exhibited by the isolates. blaOXA 
was present in 38% of the isolates and was found to be part of the In37 array in all 
of the isolates. Nucleotide sequence analysis of the amplicons identified a blaOXA-
30, which may be contributing to the amoxicillin resistance observed. Interestingly, 
although a genetic linkage between blaCTX-M and aac(6’)-Ib-cr has been reported 
before (Cordeiro et al. 2008; Kim et al. 2009b; Machado et al. 2006), blaCTX-M was 
not detected. However, all cephalosporin resistant isolates harboured qnr genes, 
thus suggesting a linkage between the presence of qnr and the resistance to 
cephalosporins as previously reported (Cavaco et al. 2007b). Strains Kp4 and 
Kp5, although negative for the presence of blaCTX-M genes, harboured qnrA, qnrB 
and blaDHA-1 encoding a plasmidic AmpC-type β-lactamase that confers resistance 
to cephamycins and extended-spectrum cephalosporins, which would explain the 
resistance to cephalosporins exhibited by these isolates. Moreover, int1 was 
detected in 81% of the isolates and 38% carried more than one integron. A total of 
10 gene cassettes occurring in 3 different cassette arrays were identified where 
the variants aadA and dfrA genes were the most frequently found (Figure 22). The 
complex integron In37 [aac(6’)-Ib-cr, blaOXA-30, catB3, arr-3]:ISCR1:qnrA1 was 
found in 8 isolates, with the same structure previously described in an E. coli 
isolate from China (accession number AY259086).  
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Figure 22 – Schematic representation of a class 1 integron found among the K. pneumoniae 
population under study. Light grey box- antibiotic resistance genes cassettes; black box- integrase 
gene, silver box, ISCR1; white box, qnrA1. Arrows indicate the direction of transcription. Solid black 
circles represent 59-base elements and grey ellipses represent the attI1 site of the integron. 
 
 
The results showed also a high association between aac(6’)-Ib-cr , blaOXA-30, class 
1 integron, ISCR1 and qnrA as previously reported in other studies, suggesting the 
dissemination of this structure in some parts of the Globe (Kim et al. 2009b; Wang 
et al. 2003 ). The gene cassette array [aac(3)Ia-orfX-orfY-aadA1] was found in 2 
isolates. This array has been described in 2001, in an A. baumannii clinical strain 
from Italy (Accession number AJ310480). The same array was also found in A. 
baumannii isolates recovered in the Hospital Infante D. Pedro, EPE (see Chapter 
4 of this thesis). The third class 1 integron gene cassette array found [dfrA12-
aadA2] was found in fifteen isolates and has also already been described in a 
Salmonella enterica environmental strain from Japan (Accession number 
AB365868). Again, these results highlight the dissemination of these resistance 
structures worldwide, in different backgrounds and between different species. All 
the three class 1 integrons arrays found harboured gene cassettes conferring 
resistance to aminoglycosides, namely aadA and aac variants, which may explain 
the resistance exhibited by the isolates to this class of antibiotics.  
An attempt to identify the reservoirs of the class 1 integron found on an active 
transposon, K. pneumoniae isolates collected in two distinct geographical regions 
were screened.  
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The rationale behind the screen of these isolates was the fact that Tn5090 an 
active transposon, was originally found in Klebsiella spp. and this species are 
common soil bacteria that live in close association with other environmental 
bacteria. 
81% (17/21) of the K. pneumoniae isolates from Portugal and 88% (32/36) of 
isolates from Libya were positive for tniC by colony blotting as described in section 
2.7.3. Isolates from each country were selected for further study and were found to 
harbour the variable region consisting of the identical gene cassettes dhfr, orfD 
and qacE found in Tn5090 (Figure 23). 
 
 
 
 
Figure 23 – Schematic representation of a class 1 integron found among the K. pneumoniae 
population under study. Light grey box- antibiotic resistance genes cassettes; black box- integrase 
gene, silver box- resistance to quaternary compounds and a transposition gene. Arrows indicate the 
direction of transcription. Solid black circles represent 59-base elements and grey ellipses represent 
the attI1 site of the integron. 
 
 
 
S1 restriction analysis of a subset of tniC positive strains indicated that the tniC 
gene was found on large plasmids of 400kb and 500kb in the isolates collected in 
Portugal (2 isolates tested) (Figure 24: 1) and 100kb to 500kb in isolates from 
Libya (7 isolates tested) (Figure 24: 2). Most of the isolates also carried the tniC 
gene on more than one plasmid and there was also evidence of the tniC gene 
being chromosomally located in a small number of bacteria.  
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Figure 24 – 1) Pulse field gel electrophoresis analysis of partially digested DNA with S1 endonuclease 
of two K. pneumoniae strains isolated in Aveiro, Portugal. Lane 1 isolate #1, Lane 2, isolate #2, Lane 3 
Bio-Rad Lambda ladder PFGE marker (Bio-Rad, California, CA, USA). 1B Autoradiography of 1A. (2) 
Autoradiography of PFGE of seven S1 digested K. pneumoniae strains isolated in Benghazi, Libya. 
 
 
The results obtained showed that tniC-like transposons such as Tn5090 were 
found to be common in K. pneumoniae strains isolated in geographically distant 
countries, in this particular case Portugal and Libya. Their common occurrence in 
K. pneumoniae suggests that this organism may provide a suitable background for 
the movement of the non-mobile, yet more common type of class 1 integron, by 
providing transposition functions in trans. Class 1 integron is most often found 
housed in a damaged transposon that has lost several mobility genes and is often 
called Tn5090-like or Tn402-like. Tn5090 itself is a transposon originally found in 
Klebsiella aerogenes that harbours a class 1 integron, has a complete set of 
transposition genes (tniA, tniB, tniC, orf6 and tniQ) and is functional. Therefore, it 
can be suggested that class 1 integrons can be divided in two groups: group 1 
where class 1 integrons are housed on an active transposon with resistance gene 
cassettes found adjacent to the tniC gene of Tn5090 (tniC-like 
integron/transposon); group 2 where class 1 integrons are found on an inactive  
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transposon that is missing the genes tniC, tniQ and a section of tniB. Group 2 
class 1 integrons also have the 3’ conserved sequence (3’CS) consisting of a 
fused qac and sul1 resistance gene cassettes that is absent from group 1. Until 
recently, nearly all class 1 integron structures found in the sequence data bases 
and in clinical bacteria were described as belonging to group 2. However, group 1 
class 1 integrons are now emerging rapidly in many places worldwide often 
carrying powerful metallo-β-lactamase gene cassettes (Toleman et al. 2007b). 
Since this form of the class 1 integron has greater mobility it can be expected to 
disseminate among Gram-negative bacteria quickly. As a consequence, bacteria 
have at their disposal one more option to disseminate structures that carry genes 
conferring antibiotic resistance, thus risking the success of antibiotic treatment. 
 
 
4.2.4 Screening of qnr genes  
Screening for the qnr genes was performed by PCR using the amplification 
conditions and primers described Material and Methods section 2.3. Fifteen out of 
the twenty-one isolates tested were positive for the presence of qnr genes (Table 
4). Twelve of them carried the qnrA1 which, in eight isolates, was found 
downstream of the In37 and ISCR1, which encodes a recombinase and provide 
the promoter sequences for high-level expression of the plasmid–mediated qnrA 
gene in Enterobacteriaceae. All the isolates co-harbouring qnrA, aac(6’)-Ib-cr and 
blaOXA-30 also harbored ISCR1 and a class 1 integron. The ampR gene was 
located downstream of the qnrA1 gene, in the position where it has been identified 
in In36 and In37. Three isolates carried the qnrB alone and four isolates were 
positive to both qnrA and qnrB simultaneously (Figure 25). qnrS could not be 
detected. 
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Figure 25 – Distribution of qnr among the K. pneumoniae isolates being studied. 
 
Previous reports described the expression of qnrA and qnrS in a E. coli clinical 
isolate from Scandinavia (Cavaco et al. 2007a). It has also been reported the co-
existance of qnrB4 and qnrS in two different plasmids found in a same clinical K. 
pneumoniae isolate from China (Aihua et al. 2008). However, we reported four 
isolates positive to both qnrA1 and qnrB4. Also, most of the qnr positive isolates 
were broad-spectrum β-lactamases producers, re-inforcing, once again, a possible 
relationship between qnr genes and broad-spectrum β-lactamases. 
These findings indicate an extremely high prevalence of the qnr genes associated 
with various resistance determinants such as ISCR1 and class 1 integrons. 
Moreover, the role of the co-existence of both qnrA and qnrB in the isolates is yet 
to be clarified, although it can be suggested that it act as a reservoir for further 
dissemination of these genes to sensitive bacteria. 
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Table 4 – Characteristics of qnrA, qnrB and qnrA/qnrB positive K. pneumoniae isolates.  
Isolate MIC µg/mL intI1 ISCR blaOXA blaCTX-M blaTEM blaSHV blaDHA qnr 
 NA CIP NOR         
KP2 ≥32 ≥4 8 - - - - blaTEM-1 blaSHV-1 - qnrA1 
KP4 ≥32 ≥4 8 + - - - - - blaDHA-1 qnrA1, qnrB4 
KP5 ≥32 ≥4 ≥16 +(In37) + blaOXA-30 - blaTEM-1 blaSHV-1 blaDHA-1 qnrA1, qnrB4 
KP6 ≥32 ≥4 8 +(In37)  + blaOXA-30 - blaTEM-1 blaSHV-1 - qnrA1, qnrB4 
KP7 ≥32 ≥4 ≥16 +(In37) + blaOXA-30 - blaTEM-1 blaSHV-5 - qnrA1 
KP8 ≥32 ≥4 8 + + - - blaTEM-1 blaSHV-1 blaDHA-1 qnrA1 
KP9 ≥32 ≥4 8 - - - - blaTEM-1 - - qnrB4 
KP11 ≥32 ≥4 8 + + - - - blaSHV-1 - qnrA1 
KP10 ≥32 ≥4 8 +(In37) + blaOXA-30 - blaTEM-1 blaSHV-1 - qnrA1, qnrB4 
KP14 ≥32 ≥4 8 +(In37) + blaOXA-30 - - blaSHV-1 blaDHA-1 qnrA1 
KP16 ≥32 ≥4 8 +(In37) + blaOXA-30 - - blaSHV-1 blaDHA-1 qnrA1 
KP17 ≥32 ≥4 8 + - - - - blaSHV-5 - qnrB4 
KP19 ≥32 ≥4 8 +(In37) + blaOXA-30 - - blaSHV-1 blaDHA-1 qnrA1 
KP20 ≥32 ≥4 8 +(In37) + blaOXA-30 - blaTEM-1 blaSHV-1 - qnrA1 
KP21 ≥32 ≥4 8 + - - - - blaSHV-1 blaDHA-1  qnrB4 
NA-Nalidixic Acid; CIP- Ciprofoxacin; NOR- Norfloxacin; (-) negative for the presence of the screened gene; (+) positive for the presence  
 of the screened gene; 
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4.2.5 Pulse field gel electrophoresis and determination of gene 
location 
 
PFGE and S1 digestion were performed as described in Material and Methods 
section 2.13. PFGE of S1-digested genomic DNA revealed the presence of high 
molecular weight plasmids, ranging from 75 kb to 450 kb, in all strains carrying qnr 
genes. S1-restricted plasmids were hybridised to labeled qnrA and qnrB-specific 
probes, as described in Material and Methods sections 2.7.1 and 2.7.2. Results 
revealed that both genes are plasmid encoded and that qnrA1 and qnrB4 are 
located on the same plasmid in two of the strains (KP4 and KP10) and on different 
plasmids in two strains (KP5 and KP6). qnrA1 gene was found on a 450kb plasmid 
in the strains KP4, KP5, KP6, KP10. qnrB4 was found located on the same 
plasmid (450kb) in two of the strains (KP4 and KP10) and in a 75 kb plasmid in 
strains KP5 and KP6. This is the first report of the presence of both qnrA1 and 
qnrB4 in the same plasmid. 
 
 
4.2.6 Matting assays 
 
Conjugation was attempted using E. coli J53 Azir as the recipient strain according 
the methodology described in Material and Methods section 2.6.2. Neither of the 
qnr genes could be transferred to E. coli J53 Azir, under the laboratory 
experimental conditions. Suggestions can be given to justify these results: 1) the 
plasmids carrying qnrA and qnrB are of such a large size (450kb) thus carrying an 
enormous amount of foreigner DNA, which can lead the cell machinery to degrade 
it; 2) Also, the plasmid may be broken during conjugation and may not be able to 
re-circularize, which once again leads to DNA degradation. Despite the fact the 
conjugation experiment failed under laboratory conditions, since the qnr genes are 
located on a plasmid it can promote its dissemination. In its natural environment, 
exchange of DNA between bacteria can occur when appropriate conditions in the 
surroundings are achieved. Under laboratory limitations, those conditions are not 
always easy to gather or adjust. 
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4.2.7 General Conclusion 
 
All the K. pneumoniae isolates included in this study were MDR. Sputum was the 
biological product from which a higher number of isolates was retrieved. ISCR1 
was detected in eight isolates closely associated with In37. blaoxa-30 when detected 
was also associated with the class 1 integron In37. The blaCTX-M gene was not 
detected in any isolate. int1 was detected in 81% of the isolates and the array 
most frequently found was [dfrA12-aadA2]. Surprisingly 17 isolates carried an 
integron inserted in a Tn5090 transposon. Fifteen isolates carried quinolone 
resistance genes. Among these, four harboured the quinolone resistance genes 
qnrA and qnrB, both located on a large plasmid in two isolates (KP4 and KP10). In 
two of the isolates (KP5 and KP6) those genes were found on different plasmids. 
Overall, these findings indicate an extremely high prevalence of the qnr genes 
associated with various resistance determinants such as ISCR1 and class 1 
integrons. 
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5.1 Introduction  
 
Among Citrobacter species, the most commonly isolated from human clinical 
specimens are Citrobacter koserii, Citrobacter freundii, Citrobacter youngae, 
Citrobacer braakii, and Citrobacter amalonaticus. Nevertheless, the majority of 
infection cases are associated with Citrobacter koseri and C. freundii (Samonis et 
al. 2009). The latter is an opportunistic pathogen that can cause diarrhoea, 
septicemia, meningitis, urinary tract and respiratory system infection, especially in 
high-risk groups (Zhang et al. 2009a). C. freundii is member of the 
Enterobacteriaceae and in China it has been ranked tenth among Gram-negative 
organisms considered nosocomial resistant pathogens, despite being traditionally 
considered to have low level of virulence (Zhang et al. 2009a). A study performed 
by Samonis and co-workers (2009) revealed that the isolation of Citrobacter 
species, although rather infrequent, was clinically relevant in the vast majority of 
cases. Therefore, as suggested by Samonis and co-workers (2009), further 
attention should be given to these pathogens. 
Quinolones are broad-spectrum antibiotics that have been widely used in clinical 
practice (Andriole 2005). The increasing use of fluoroquinolones has triggered an 
increase of resistance in Enterobacteriaceae that originally were highly susceptible 
to this class of antibiotics (Robicsek et al. 2006). qnr genes have been 
hypothesized to contribute to the increasing prevalence of quinolone resistance 
among Gram-negative bacteria. Epidemiological surveys around the world have 
found qnrA, qnrB, and qnrS in various Enterobacteriaceae such as C. freundii, E. 
coli, Enterobacter cloacae, Enterobacter sakazakii and K. pneumoniae (Cavaco et 
al. 2007b). Frequently, quinolone resistance and ESBL production are associated. 
This can be due to the plasmid mediated ESBL and qnr genes that are often 
associated with mobile elements, such as integrons and ISCR elements (Machado 
et al. 2005). This study is focused on a C. freundii possessing a wide range of 
antibiotic resistance determinants, such as integrons, blaCTX-M-15, ISCR1 and qnr 
genes.  
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5.2 Results and Discussion 
5.2.1 Clinical context of CIT1 recovery  
 
The C. freundii isolate, CIT1, was recovered from a 17-year-old boy admitted in 
mid-August 2008, with the diagnosis of dorso-lumbar spondylodiscitis caused by 
methicillin-sensitive Staphylococcus aureus (MSSA). The patient was initially 
treated with flucloxacillin (2g q4h IV) and subsequently with teicoplanin (12mg/Kg 
od IV, with initial loading dose). The patient was henceforth discharged, and 
teicoplanin treatment continued to be administered as an outpatient. After 
discharge, clinical signs (severe chills, cyanosis of lips and extremities and, 
afterwards, fever) of a bloodstream infection were observed. The patient was re-
admitted, maintaining the teicoplanin treatment, and imipenem 1gq 8h IV was 
empirically started. Within the central venous catheter grew a Gram-negative 
bacillus (CIT1 specimen), later identified as C. freundii. Imipenem treatment was 
maintained for 14 days, and the patient recovered.  
 
 
5.2.2 Species identification and antibiotic susceptibility testing  
 
Species identification was performed using the VITEK2 Compact system and the 
AES (bioMérieux, Marcy L´Étoile, France). AES highlighted six MDR C. freundii, 
during 2008. Among these isolates one particular isolate, CIT1, isolated from 
blood, showed a high antibiotic resistance profile. Susceptibility testing was carried 
out according to guidelines of CLSI standards (CLSI 2007).  
C. freundii, CIT1, was resistant to all β-lactams tested: ampicillin (≥ 32 µg/mL), 
ampicillin/ sulbactam (≥ 32 µg/mL), amoxicillin/ clavulanic acid (≥ 32 µg/mL), 
cefotaxime (≥ 64 µg/mL), ceftazidime (≥ 32 µg/mL), cefepime (≥ 32 µg/mL), 
piperacillin (≥ 128 µg/mL) and piperacillin/tazobactam (≥ 128 µg/mL). Susceptibility 
was only shown to the carbapenems: imipenem (≤ 1 µg/mL) and meropenem (≤ 1 
µg/mL). Resistance to aminoglycosides: gentamicin (≥ 16 µg/mL) and tobramycin 
 
Carriage of qnrA1 and qnrB2, blaCTX-M-15 and complex class 1 integron in a clinical multi-resistant Citrobacter freundii isolate 
  111 
(≥ 16 µg/mL); and to fluoroquinolones: ciprofloxacin (≥ 4 µg/mL) and norfloxacin (≥ 
16 µg/mL), was also observed. ESBL production was detected using Etest ESBL 
with cefotaxime/ cefotaxime + clavulanic acid (CT/CTL), ceftazidime/ ceftazidime + 
clavulanic acid (TZ/TZL) and cefepime/ cefepime + clavulanic acid (PM/PML) 
strips according to the manufacturer’s instructions (AB bioMérieux, Solna, 
Sweden). Etest CT/CTL and TZ/TZL gave an inconclusive result, but PM/PML 
confirmed that CIT1 was an ESBL producer (Figure 26). The inconclusive results 
obtained with CT/CTL and TZ/TZL Etest strips may be explained by the presence 
of an ampC β-lactamase. It is known that C. freundii possesses a chromosomal 
CMY AmpC and it is also known that clavulanic acid induces its expression, thus 
enhancing the resistance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26 – Muller-Hinton agar (bioMérieux, France) plate showing a PM/PML Etest strip (bioMérieux, 
France) positive result for the presence of an ESBL in the C. freundii isolate. 
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5.2.3 Matting assays 
 
Conjugation experiments were performed using E. coli J53 Azir as the recipient 
strain as previously described in Material and Methods section 2.6.2. Conjugation 
was unsuccessful, under the various laboratory experimental conditions tested. 
qnrA and qnrB were detected in the plasmid DNA but not in the chromosomal DNA 
of C. freundii CIT1, implying that qnrA or qnrB were plasmid encoded. 
Hybridization experiments confirmed that qnrA and qnrB are in located on the 
same plasmid of 450kb. The large size of the plasmid can explain the 
unsuccessful conjugation assay. 
 
5.2.4 ISCR, class 1 integrons and β-lactamase genes content 
 
PCR was performed to detect the presence of β-lactamase genes belonging to the 
blaSHV, blaCTX-M, blaTEM, blaOXA groups, plasmidic AmpC (DHA, MOX, FOX, CMY 
and ACC) families, as well as qnr genes, class 1 integrons, ISEcp1, ISCRs and 
tniC transposons. Amplification conditions and primers used were previously 
described in the Material and Methods section 2.3. Nucleotide sequence of PCR 
products was determined and compared to others deposited in the European 
Molecular Biology Laboratoty (EMBL) Genebank. PCR and nucleotide sequence 
analysis revealed the presence of ISEcp1 linked to a blaCTX-M-15 (Accession 
number FJ459818), which may explain the resistance exhibited by this isolate to 
third generation cephalosporins, as previously described by Eckert et al, 2006. 
ISEcp1 has been reported to act as a strong promoter positively regulating the 
expression of blaCTX-M-15 and also responsible for its mobilization (Poirel et al. 
2003). Genes encoding blaOXA-30 and blaTEM-1 were also detected and may 
contribute for the penicillin resistance exhibited by CIT1, namely to ampicillin. As 
expected, the CMY ampC was also detected in CIT1 once that it has been 
accepted that CMY originates from the chromosome of the C. freundii species 
(Barlow and Hall 2002; Hanson 2003).  
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In typical E. coli and Shigella species, ampC is expressed at such low levels that 
deletion of ampC does not affect sensitivity to β-lactams. However, in C. freundii 
and Enterobacter cloacae, ampC is inducible by both penicillins, such as 
ampicillin, and by cephalosporins (Barlow and Hall 2002). Due to their location on 
the host chromosomes, ampC genes were not initially subjected to the rapid 
dissemination promoted by the horizontal transfer of plasmid-borne genes (Barlow 
and Hall 2002). However, some ampC genes jumped into plasmids, which 
enhanced their fast dissemination between species and around the world.  
This is also the first description of a complex class 1 integron structure [dfrA12, 
orfF, aadA2]:ISCR1:qnrA1 in C. freundii (Figure 27). Interestingly, class 1 integron 
array [dfrA12, orfF, aadA2] has been reported associated with the sul3 gene in E. 
coli strains from animal sources in Norway and Denmark (Sunde et al. 2008). This 
suggests a dissemination of this structure, in different genetic contexts and 
environments, but in either case plasmid located. 
 
 
Figure 27 – Schematic representation of the class 1 integron associated with ISCR1 and qnrA1 that 
was found in the CIT1 isolate. Light grey box- antibiotic resistance genes cassettes; black box- 
integrase gene, silver box, ISCR1; white box, qnrA1. Arrows indicate the direction of transcription. 
Solid black circles represent 59-base elements and grey ellipses represent the attI1 site of the 
integrants found in the C. freundii isolate CIT1. 
 
5.2.6 Screening of qnr genes  
 
PCR amplification and nucleotide sequence analysis of the resulting amplicon, 
revealed the presence of both qnrA1 and qnrB2 in CIT1 plasmid DNA (Figure 28). 
Their genetic context and location was further investigated. Amplification 
conditions and primers were previously described in Material and Methods section 
2.3. Plasmid DNA was extracted by alkaline lyses according to the protocol 
described in Material and Methods section 2.5.2. 
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Hitherto, qnrA1, has never been found in C. freundii, and in CIT1 it is associated 
with a class 1 integron, [dfrA12, orfF, aadA2] and ISCR1 as shown in Figure 28. 
qnrA1 was found downstream of the ISCR1. The class 1 integron has been 
previously described within a highly transmissible plasmid in a C. freundii isolate 
(Acession Number NC_004464). However, in that particular case it was neither 
associated with ISCR1 nor with a qnrA gene. Despite being carried on the same 
plasmid, qnrB2 (Accession Number FJ232918), was not found associated with 
either ISCR1, tniC or ISEcp1. Its genetic context could not be determined, despite 
all the attempts made and based on the genetic contexts previously described in 
the literature, for other qnrB genes. 
This is the first report of the presence of qnrA1 and qnrB2 in C. freundii isolate. 
Quinolone MIC value does not reflect a clear advantage to this strain of carrying 
both genes, when compared to other bacteria carrying only one of the genes. 
However, it might contribute to an increased resistance of the strain when 
subjected to quinolone selective pressure. Although responsible for low-level 
quinolone resistance, in the presence of other encoded resistance 
genes/mechanisms, qnr genes may be an important tool for bacteria to avoid 
lethal quinolone concentrations. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28 – PCR amplification of qnrA and qnrB in CIT1 plasmid DNA; M – DNA size marker GeneRuler 
Ladder mix (MBI Fermentas, Vilnius, Lithuania); 1 – qnrA gene; 2 – qnrB gene; 3 – qnrA positive 
control; 4 – DNA negative control; 5 – qnrB positive control. 
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5.2.7 Pulse field gel electrophoresis and determination of gene 
location 
 
PFGE and S1 digestion of genomic DNA were performed as described in Material 
and Methods section 2.7.11. Hybridisation and DNA probe labeling were 
performed according to the methodology described in sections 2.7.1 and 2.7.2. 
PFGE of S1-digested genomic DNA revealed the presence of two plasmids in 
CIT1 isolate. C. freundii isolates carrying more than one plasmid have already 
been described by other authors (Sekiguchi et al. 2008; Zhang et al. 2009a). 
Previous studies reported that plasmids with higher molecular weight were 
associated with several antibiotic resistance genes, such as those conferring 
resistance to β-lactams (Sekiguchi et al. 2008). Nevertheless plasmids with the 
molecular weight ranging between 40-450Kb such as those found in CIT1 strain 
have never been described in C. freundii. 
Hybridisation results revealed that qnrA and qnrB genes were located on the same 
large plasmid of approximately 450kb as shown in figure 29. 
Moreover, qnrA1 and qnrB2 (Accession number FJ232918) were located on the 
same plasmid and are here reported for the first time in this species and with this 
location; nevertheless other studies performed with K. pneumoniae clinical 
isolates, reported the presence of these two genes also on the same plasmid 
(Ferreira et al. 2008). Interestingly, both isolates (K. pneumoniae and C. freundii) 
carrying both qnrA1 and qnrB2 genes in large plasmids (450kb), were recovered 
from different biological specimens (sputum and catheter, respectively) from 
inpatients in distinct wards (Intensive Care Unit and Infectious Diseases, 
respectively) within the same hospital and in different timeframes. However, in 
both cases, qnrA1 was associated with a class 1 integron and an ISCR1, and this 
complex structure was located on a plasmid of similar size. This fact suggests the 
potential of dissemination of these resistance determinants. In fact, hybridisation 
data suggest that all these structures are found on the same plasmid permitting 
their further dissemination.  
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Figure 29 – (1A) M – Bio-Rad lambda ladder PFGE marker (Bio-Rad, California, CA, USA); CIT - C. 
freundii DNA digested with S1 nuclease. Arrows denote molecular weights of the marker; (1B) 
Autoradiography of (1A) with qnrA probe: (1C) Autoradiography of (1A) with qnrB probe. 
 
 
5.2.8 ISCR1 as qnrA1 promoter 
 
It has been reported that ISCR1, encoding a recombinase, provides the promoter 
sequences necessary for high-level expression of plasmid–mediated qnrA gene in 
Enterobacteriaceae (Rodriguez-Martinez et al. 2006). Figure 30 shows the multiple 
alignments of C. freundii  (CIT1), E. coli (GenBank accession AM295981.1) and K. 
pneumoniae (GenBank accession EF682136) ISCR nucleotide sequences, 
including 33 bp DNA sequence containing oriIS and the start codon of the qnrA 
gene. ClustalW comparison of these sequences, revealed a strong homology with 
the C. freundii promotor sequence. It also shows that ISCR1, as revealed by the 
comparison with other sequences, promotes qnrA1 expression in CIT1. 
Furthermore, analysis of the genetic environment surrounding the 3’ end of the 
DNA sequence containing oriIS revealed that the upstream sequence of qnrA in 
CIT1 and E. coli had an additional 69 bp compared to the upstream sequence of 
Carriage of qnrA1 and qnrB2, blaCTX-M-15 and complex class 1 integron in a clinical multi-resistant Citrobacter freundii isolate 
  117 
K. pneumoniae. This indicates that the variation in these genetic environments 
might be due to past transposition events by the ISCR1 upstream of the qnrA 
gene, as also reported by other authors (Sohn et al. 2009). 
 
C.freundii CIT1    TTTGACTGACGACCCCAAATCCAACACTGCTCAACACTGCCAACTTTTAA 50 
E.coli             TTTGACTGACGACCCCAAATCCAACACTGCTCAACACTGCCAACTTTTAA 50 
K.pneumoniae       TTTGACTGACGACCCCAAATCCAACACTGCTCAACACTGCCAACTTTTAA 50 
                   ************************************************** 
 
C.freundii CIT1    ACGGGGCGGTGGGGCAGTTTGTATCTCTCGAGCTATCAGGCTAGAGATTT 100 
E.coli             ACGGGGCGGTGGGGCAGTTTGTATCTCTCGAGCTATCAGGCTAGAGATTT 100 
K.pneumoniae       ACGGGGCGGTGGGGCAGTTTGTATCTCTCGAGCTATCAGGCTAGAGATTT 100 
                   ************************************************** 
 
C.freundii CIT1    TACCGCCAAATCGAACCTTATTAGAGCGGTTTAGGCTGGACCGGCAGTTA 150 
E.coli             TACCGCCAAATCGAACCTTATTAGAGCGGTTTAGGCTGGACCGGCAGTTA 150 
K.pneumoniae       TACCGCCAAATCGAACCTTATTAGAGCGGTTTAGGCTGGACCGGCAGTTA 150 
                   ************************************************** 
 
C.freundii CIT1    AAATTGGGGCTTGAGCGGTAAACGAGTGAGGGAATTTCAGGTAAGATACT 200 
E.coli             AAATTGGGGCTTGAGCGGTAAACGAGTGAGGGAATTTCAGGTAAGATACT 200 
K.pneumoniae       AAATTGGGGCTTGAGCGGTAAACGAGTGAGGGAATTTCAGGTAAGATACT 200 
                   ************************************************** 
 
C.freundii CIT1    TCGGATGAGGAGCAAAAAGGTGGTTTATACTTCCTATACCCCTGCAAAGG 250 
E.coli             TCGGATGAGGAGCAAAAAGGTGGTTTATACTTCCTATACCCCTGCAAAGG 250 
K.pneumoniae       TCGGATGAGGAGCAAAAAGGTGGTTTATACTTCCTATACCC--------- 242 
                   ***************************************** 
 
C.freundii CIT1    TTGTTGGGAAGGCGCGAACCAACCCCATGTTTGCCTGCCTAGGCAAAGCT 300 
E.coli             TTGTTGGGAAGGCGCGAACCAACCCCATGTTTGCCTGCCTAGGCAAAGCT 300 
K.pneumoniae       -------------------------------------------------- 242 
                     
 
C.freundii CIT1    CGCCGAAAGAGTTAGCACCCTCCCTGATTAAAGGAAGCCGTATG 344 
E.coli             CGCCGAAAGAGTTAGCACCCTCCCTGATTAAAGGAAGCCGTATG 344 
K.pneumoniae       ----------GTTAGCACCCTCCCTGATTAAAGGAAGCCGTATG 275 
                             ********************************** 
 
Figure 30 – Comparison of the C. freundii ISCR1 nucleotide sequence (GenBank accession FJ266018) 
with other ISCR1 nucleotide sequences (GenBank accession AM295981.1 and EF682136). ISCR1 OriIS 
of transposition is represented by the black rectangle and initiation codon of qnrA gene is represented 
by the dashed rectangle.  
 
 
5.2.9 General Conclusion 
 
The MDR C. freundii recovered from a catheter of a patient, carried an ISCR1, a 
qnrA1 and qnrB2, blaCTX-M-15 and a complex class 1 integron that is described for 
the first time in this species. This isolate harboured the quinolone resistance 
genes, qnrA1 and qnrB2, both located on a large plasmid (450kb). Analysis of the 
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nucleotide sequence of ISCR1 showed that it provides a promoter for the qnrA 
gene associated with it. Moreover, the results also suggest that isolates, which are 
not commonly linked to sepsis, rather to opportunistic infections, can be a 
reservoir of antibiotic resistance genes that can be transferred to other bacteria. 
Therefore these reservoirs represent a threat within the hospital environment. 
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6.1. Introduction 
 
Acinetobacter spp., specially Acinetobacter baumannii, are frequently associated 
with nosocomial infections, particularly in intensive care units, where their ability to 
resist to dryness can pose substantial problems in their eradication from the 
environment. They have also been recognized as invaders of burn wounds 
(Hawkey 2008; Livermore and Woodford 2006). Acinetobacter spp. produce a 
wide range of β-lactamases and have a formidable spectrum of intrinsic resistance 
mechanisms, meaning that some strains are resistant to all known antibiotics with 
the exception of colistin (Hawkey 2008). It is also notoriously associated with 
outbreaks, facilitated by resistance to disinfectants and desiccation (Livermore and 
Woodford 2006). Some strains of A. baumannii became MDR by sequestering 
antibiotic resistant genes present on plasmids, transposons, or integrons carrying 
arrays of genes encoding resistance to several antibiotic families (Fournier et al. 
2006). ISCR elements are becoming increasingly important due to their 
association with various antibiotic resistance genes. ISCRs can be broadly 
classified into 2 groups, ISCR associated to class 1 integrons and ISCR non 
associated with class 1 integrons (Toleman and Walsh 2008). The recent genomic 
sequence of the A. baumannii strain AYE by Fournier et al. (2006) revealed the 
presence of two ISCR elements, ISCR1 as part of a complex class integron and 
ISCR3; however, hitherto these are the only two ISCR elements to be denoted 
from this organism (Poirel, personal communication). 
ISCR2 element sequences deposited in DNA data-bases are invariantly found 
adjacent to antimicrobial resistance genes although they are usually described as 
“putative transposases” and not ISCR elements. ISCR2 is intimately associated 
with antimicrobial resistance genes especially sulphonamide (sul2) and 
trimethoprim (dhfr9, dhfr18, dhfr20) in Escherichia coli, Stenotrophomonas 
maltophilia and Vibrio cholerae (Toleman et al. 2006b).  
 
 
ISCR database: http://www.cardiff.ac.uk/medic/aboutus/departments/medicalmicrobiology/genetics/iscr.html 
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ISCR2 has also been found located on a number of plasmids adjacent to 
chloramphenicol/florphenicol resistance gene, floR, sometimes on the novel 
integrative and conjugative multidrug resistance encoding genetic element SXT. 
ISCR2 elements have now been found in several bacterial species and in different 
geographical and ecological environments (Toleman et al. 2006b).  
This study describes the first cases of ISCR2 in A. baumannii from Portugal as 
well as their novel genetic context. Retrospective studies also show the presence 
of ISCR2 since 1995.  
 
 
6.2 Results and Discussion 
6.2.1 Background of the A. baumannii isolates  
 
Seventeen MDR A. baumannii were recovered from various clinical specimens 
(urine (5), pus (4), sputum (7), and blood (1) Figure 31) that were collected in the 
Hospital Infante D. Pedro EPE, Aveiro, central region of Portugal, in different 
timeframes (2006, 2007 and 2008). All of the isolates were recovered after 72 h of 
patient admission, thus suggesting a nosocomial infection. Acb17 isolate was 
collected in 2006, it was a MDR isolate causing respiratory tract infection and 
ultimately the patient’s death. This particular isolate was further studied, since it 
was recovered from a patient hospitalized in the ICU new facility. At that time this 
episode caused extreme concern since the source of contamination was not 
identified and the possibility of an outbreak was considered, as it later turned out 
to be true. The isolates collected in 2007 were recovered during an outbreak that 
occurred in the hospital and spread to the different wards. In 2008, after the 
implementation of several decontamination measures, two isolates (Acb15 and 
Acb16) were again collected from patients hospitalised in the ICU. 
A. baumannii isolates collected in Coimbra (one isolate) and in Argentina (two 
isolates) were included in this study merely for comparison purposes. The isolate 
collected in Coimbra, AcbHUC, was used for resistance profile comparison and 
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also as positive control to the presence of blaOXA-40. The Argentinean isolates were 
used as positive controls for the presence of ISCR2 and for genetic context 
comparison. 
A higher number of isolates were recovered from sputum, as expected, since most 
of these patients have been diagnosed with a respiratory tract infection. It is, 
however noteworthy that from other specimens, with the exception of blood, 
similar number of isolates were recovered in the different specimens, suggesting 
the ubiquity of this species and its adaptability to different conditions, and 
ultimately to cause infection.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31 – Biological products from which the A. baumannii isolates were recovered are indicated in 
the vertical axis. The number of isolates recovered from each product is indicated in the horizontal 
axis. 
 
The patients age was comprised between 45 and 87 years old. The majority of the 
isolates were recovered from patients with ages above the 60 years. The 
Acinetobacter species are commonly found associated to nosocomial infections 
that frequently become colonizations. Thus it is predictable that patients with 
extended hospitalization periods are likely to be infected, independent of their age. 
It is common sense that the elderly that often need medical care and are more 
debilitated and thus more exposed to A. baumannii nosocomial infections. 
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However, and among the population studied, some isolates were retrieved from 
middle age patients, which suggest that in this case and during an outbreak the 
probability of an infection caused by an A. baumannii is age independent.  
 
6.2.2 Species Identification and antibiotic susceptibility testing  
 
Species identification was performed using in the VITEK2 system and AES 
(bioMérieux, Marcy L´Étoile, France). Susceptibility testing was carried out 
according to the guidelines of CLSI standards (CLSI 2007).  
Antibiotic susceptibility testing revealed, as expected, that the A. baumannii 
isolates collected were MDR, exhibiting a similar multidrug resistance pattern. As 
described in other studies performed in Portugal, MDR A. baumannii has 
increasingly been recognized as responsible for large and sustained outbreaks of 
nosocomial infections (Silva et al. 2007). The A. baumannii population studied 
showed a resistance profile similar to that described by da Silva and colleagues 
(2007) in isolates collected from different hospitals in the country. The isolates 
included in the present study were resistant to all the β-lactams tested including 
resistance to amoxicillin and to the association of amoxicillin with clavulanic acid, 
ureidopenicillins and their associations, cefoxitin, ceftriaxone, ceftazidime, 
cefepime, cefpirome, aztreonam (MICs between 64 and > 256  µg/mL), 
ampicillin/sulbactam (MIC of 64  µg/mL) and resistance to imipenem (MIC 
>16  µg/mL). Fifteen isolates were resistant (MIC ≥ 4 µg/mL) and two were 
susceptible to ciprofloxacin (MIC < 4 µg/mL). The susceptibility profile to 
aminoglycosides was variable. Seven isolates were susceptible to gentamicin 
whereas eight were susceptible to tobramycin. MICs of representative antibiotics 
of each class are listed in Table 5. All the isolates were susceptible to colistin. 
Thus, colistin and in some cases aminoglycosides were the antibiotics left in the 
narrow list of options to treat infections caused by these A. baumannii isolates.  
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Table 5 – Demographic details, MIC values and presence of ISCR2 and class 1 integrons in A. 
baumannii population included in this study. 
IMI- imipenem; CTZ- ceftazidime; ATZ- aztreonam; GENT- gentamicin; TOB- tobramycin; CIP- 
ciprofloxacin 
 
 
 
 
 
Strains 
Collection 
year 
MIC ( µg/mL) 
ISCR2 
Positive 
Class 1 
integron 
  IMI CTZ ATZ GENT TOB CIP   
Acb1 2007 ≥16 ≥64 >64 1 1 ≥4 + + 
Acb2 2007 ≥16 ≥64 >64 2 1 ≥4 + + 
Acb3 2007 ≥16 ≥64 >64 1 1 0.5 - - 
Acb4 2007 ≥16 ≥64 >64 ≥16 0.5 ≥4 + + 
Acb5 2007 ≥16 ≥64 >64 2 1 ≥4 + + 
Acb6 2007 ≥16 ≥64 >64 1 1 ≥4 + + 
Acb7 2007 ≥16 ≥64 >64 ≥16 8 ≥4 + + 
Acb8 2007 ≥16 ≥64 >64 ≥16 8 ≥4 + + 
Acb9 2007 ≥16 ≥64 >64 ≥16 >16 ≥4 + + 
Acb10 2007 ≥16 ≥64 >64 1 1 0.5 - - 
Acb11 2007 ≥16 ≥64 >64 ≥16 8 ≥4 + + 
Acb12 2007 ≥16 ≥64 >64 1 1 ≥4 + + 
Acb13 2007 ≥16 ≥64 >64 8 8 ≥4 + + 
Acb14 2007 ≥16 ≥64 >64 8 8 ≥4 + - 
Acb15 2008 ≥16 ≥64 >64 8 8 ≥4 + + 
Acb16 2008 ≥16 ≥64 >64 8 8 ≥4 + + 
Acb17 2006 ≥16 ≥64 >64 8 8 ≥4 + + 
AcbHuc 1995 ≥16 ≥64 >64 8 8 ≥4 + - 
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6.2.3 Characterization of ISCR2 genetic context  
Amplification conditions and primers used are described in Material and Methods 
section 2.3. Fifteen out of the seventeen isolates were positive for the presence of 
the ISCR2 element. The A. baumannii isolates tested seem to be identical in that 
they possessed only a single copy of the ISCR2. The genetic context of the further 
to the left and right hand side of the ISCR2 was investigated using the 
methodology described in Material and Methods section 2.8. Results obtained 
revealed a truncated lysR gene followed by a resolvase gene to the left hand side 
of ISCR2 and a truncated phospho-glucosamine mutase gene, glmM immediately 
to the right hand side followed by a sul2 gene (Figure 32). Analysis of this locus 
indicated that the G+C content of each reading frame was 59.9-60.3% and does 
not derive from the Acinetobacter spp. (average G+C content of 39%), but may 
have collectively originated from a single organism with a G+C % of approx. 60%. 
Comparisons with other ISCR2 structures in the database showed that these 
sequences are unique in that they possess the sul2 gene. The only other structure 
reported thus far not to have a second part-copy of ISCR2 was reported from 
Stenotrophomonas maltophilia isolated from the USA in 2006 (accession number 
AM181666).  
Sequence analysis of the 7150bp ISCR2 locus from the two A. baumannii 
collected in Argentina and used for comparison (Acb23 and Acb25) indicated that 
two identical ISCR2 elements (referred to as ISCR2A and ISCR2B) were found 
flanking a 2.4 kb section of DNA. This section included a floR resistance gene and 
a 305bp transcriptional regulator gene encoding a LysR-type protein immediately 
downstream of floR; the second copy of ISCR2 was also adjacent to a sul2 gene 
and a truncated glmM (Figure 32). Comparison of these two tandem repeated 
ISCR2 elements showed that they are almost identical. Alignment of the 
ISCR2A/B oriIS sequences (to the right hand side of ISCR2) and adjacent DNA 
revealed identical sequence until the junction between the oriIS and the adjacent 
sequence, where the identity was abruptly lost. This indicates that the two ISCR2 
elements were originally produced by replicative transposition events rather than a 
duplication event through homologous recombination.  
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Comparisons of the genetic context of the ISCR2/floR/ISCR2 fragments from 
Acb23 and Acb25 to similar sequences in the databases revealed a number of 
structures containing floR gene also flanked by full length or truncated copies of 
ISCR2 genes. The sequence of this section has high identity and also the same 
gene arrangement found in the E. coli BN10660 plasmid (Accession number 
AF231986) isolated in France in 2000. A similar ISCR2 region has been reported 
where the authors detected circular intermediate forms of the element and related 
this to the potential mobility of floR gene (Doublet et al. 2005). In three other 
cases, this gene arrangement is similar to sequences from Vibrio cholerae strain 
V21 isolated from Viet Nam in 2003 (AB114188), from plasmid pAb5S9 isolated 
from Aeromonas bestiarum in France in 2007 (EF495198) and from plasmid 
pSN254 isolated from Salmonella enterica SL254 in 2007 (CP000604) where floR 
gene is flanked by a full copy of the ISCR2 gene on left hand side, but only has 
300-500bp of a truncated ISCR2 gene on the right hand side. Other floR genes 
have adjacent and truncated copies of ISCR2 on the left right hand side as it has 
been found in isolates from Germany and India in 2005, which have arisen as a 
result of a deletion event.  
This was the first report of the presence of an ISCR2 in A. baumannii and 
highlights the universal and the unusual antibiotic resistant mobile element 
distributed in different geographical locations. South American isolates were 
chosen as has been shown that ISCR4 is associated with blaSPM-1 (Poirel et al. 
2004) and it would be insightful to see if this had spread to other species. 
Interestingly both structures possess sul2 but only the Argentinean isolates 
possess floR suggesting that one structure has evolved from the other. The 
insertion of a second copy of ISCR2(A) and floR by a transposition event was 
followed by homologous recombination. 
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Figure 32 – Genetic context of ISCR2 fragment compared with similar regions containing ISCR2. Open 
reading frames are indicated with open boxes and the direction of their transcription indicated with 
arrows below the boxes. The ISCR2 elements are denoted by diagonal lines reading left to right. floR 
gene denoted by diagonal lines reading right to left; lysR a black box; glmM a white box, sul2 a 
chequered box and resolvase gene a dark grey box. All other open reading frames are denoted by 
grey boxes. 
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6.2.4 Pulse-field gel electrophoresis and hybridisation 
experiments 
 
PFGE was performed as described the Material and Methods in section 2.11 using 
SmaI endonuclease (MBI Fermentas, Vilnius, Lithuania). PFGE DNA profiles 
obtained by of the aforementioned isolates were separated in four different 
clusters, according to the Tenover criteria (Tenover et al. 1995). One particular 
Portuguese cluster in which the isolates differ by only two or less bands, revealed 
the presence of a blaOXA-40 gene. These clones were already identified and their 
dissemination has been fully described by Da Silva and colleagues (2004), as 
belonging to the European clone. Unsurprisingly, the Argentinean strains showed 
a distinctively different pattern from that of the Portuguese isolates.  
S1 digestion of chromosomal DNA clearly revealed the presence of large plasmids 
in eleven strains (Figure 33). Plasmids size ranged from 180kb (4 isolates) to 
250kb (7 isolates). The results from the ISCR2-specific hybridisation performed on 
the S1-digested plasmids demonstrated that the ISCR2 is not plasmid encoded 
since no positive hybridisation signal from non-chromosomal DNA fragments was 
observed further confirming that in all isolates, ISCR2 is present on the 
chromosome (Figure 33).  
  
  
Figure 33 – ISCR2 hybridisation of S1 digested A. baumannii DNA. Lanes 1-7 and 9-12 represent Acb1-
Acb7 and Acb9-Acb12, respectively. Lane 8: Bio-Rad lambda ladder PFGE marker (Bio-Rad, 
Richmond, CA, USA). Arrow indicates the presence of high molecular weight plasmids. 
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6.2.5 Class 1 integrons and β-lactamase genes content  
 
The presence of class 1 integrons in A. baumannii has been significantly 
associated with multiple antibiotic resistance and the nosocomial dissemination of 
these isolates has been described worldwide (Luna and Aruj 2007). Amplification 
conditions and primers used were previously described in the Material and 
Methods section 2.3. Screening of intI1 gene in the population under study and the 
subsequent variable regions amplification in the positive isolates, revealed an 
expected genetic stability with limited diversity of gene cassettes. PCR 
amplification and nucleotide sequence analysis of the resulting amplicons, 
revealed the presence of only two distinct arrays. The gene cassette array found 
[aac(3)Ia-orfX-orfY-aadA1] was described in 2001, in an A. baumannii clinical 
strain from Italy (Accession number AJ310480). The second integron found 
contained a single gene cassette in its variable region and an aadA1 gene 
encoding aminoglycoside resistance. Similar results were reported in a study 
performed with isolates collected from the major Portuguese teaching hospitals 
(Pereira et al. 2008). Although a high prevalence of genes encoding 
aminoglycoside-modifying enzymes have been reported among A. baumannii 
integrons, they contribute for a limited resistance. Nevertheless, similar integrons 
can be found in genotypically distant Acinetobacter spp. isolates from distant 
locations suggesting their dissemination worldwide (Looveren and Goossens 
2004). 
One of the main concerns about antimicrobial resistance in A. baumannii has been 
the acquisition of carbapenem resistance mainly through the acquisition of class B 
and D carbapenemases. Screening by PCR for carbapenemase encoding genes 
revealed the presence of blaOXA-40 in seven isolates (41%). The presence of the 
promoter sequence, ISaba1 was also investigated by PCR and was found 
upstream of the blaOXA-40 in all the positive isolates. As reported by other authors 
ISaba1 insertion sequence can act as a strong promoter of blaOXA-40 conducting to 
its hiper-expression, which leads to carbapenem resistance (Heritier et al. 2005). 
Long-term dissemination of a blaOXA-40 producer A. baumannii in the Iberian 
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Peninsula has been reported by da Silva and co-workers, thus unsurprisingly it 
was detected in our hospital (Da Silva et al. 2004).  
 
6.2.6 Retrospective studies on the A. baumannii, AcbHUC  
During the course of the study, it was deemed prudent to use an established strain 
as a negative control for ISCR2 and sul2 screening and for this purpose, AcbHUC 
was chosen once it was first isolated in 1995. Surprisingly, AcbHUC was shown to 
possess an identical structure to that found in the other Portuguese isolates 
derived from 2007. ISCR2 was retrospectively shown to be part of the RSF1010 
plasmid (Radstrom and Swedberg 1988) and therefore has been circulating for 
decades but so far this is the earliest report of it presence in clinical bacteria.  
 
6.2.7 General Conclusion 
The vast majority of the A. baumannii population studied was found to be only 
sensitive to colistin and to the aminoglycosides. ISCR2 was present in seventeen 
isolates, is chromosomally located and it is embedded within a novel genetic 
context. Large plasmids (180 kb and 250 kb) were detected in eleven isolates. 
Screening of class 1 integrons revealed a genetic stability and only two distinct 
arrays were found. blaOXA-40 was detected in seven isolates and in all of them it is 
associated with ISaba1 representing a major threat since the latter it is known to 
act as a strong promoter. This association has been reported to be responsible for 
carbapenem resistance (Heritier et al. 2005). The endemic A. baumannii, here 
described was found to belong to the European clone II that is disseminated since 
1998 in some Portuguese hospitals. These MDR microorganisms represent a 
serious problem since a limited choice of antibiotics can be used to treat infections 
caused by these bacteria. 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7. Chapter 5 – Screening of ISCR elements in 
environmental isolates 
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7.1 Introduction 
 
Nowadays, antibiotics are widely used in human and animal health or as food 
additives to promote animal growth rate (Kemper 2008). A negative consequence 
of the present panorama is the fact that the majority of these antibiotics are 
excreted unchanged into the environment. Thus, concerns about the potential 
impact of antibiotic residues in the aquatic environment have increased in recent 
years (Zhang et al. 2009b). Moreover, antibiotic resistance in the environment is 
becoming highly relevant to human health mainly due to the increasing importance 
of zoonotic diseases as well as the need for predicting emerging resistant 
pathogens (Allen et al. ). However, although the scientific community agrees that 
the use of antibiotics may accelerate the development of antibiotic resistance 
genes in bacteria, the environmental reservoirs of resistance determinants are 
poorly understood. The emergence of antibiotic resistance genes in the water 
environment is becoming an increasing source of concern worldwide. Hundreds of 
various genes encoding resistance to a broad range of antibiotics have been found 
in microorganisms distributed in both hospital and animal production wastewaters, 
but also in sewage, wastewater treatment plants, surface water, groundwater, and 
even in drinking water (Zhang et al. 2009b). The emergence of those genes in 
aquatic environments is a consequence of the intensive antibiotic usage in 
hospitals, swine production areas, and fish farms (Chee-Sanford et al. 2001). 
Among the genetic mechanisms involved in horizontal gene transfer between 
environmental bacteria is the conjugative transfer by mobile elements including 
plasmids, transposons, integrons embedded on plasmids or transposons and 
insertion sequences (Zhang et al. 2009b). 
The previous chapters clearly showed a prevalence of ISCRs in the biased 
hospital environment. However, the prevalence and route of dissemination of 
ISCRs in the community is not so clear and needed further investigation. Ria de 
Aveiro, Portugal and other environments geographically separated (Cardiff lakes) 
were investigated to determine whether location was a biased factor for the 
occurrence of ISCRs. To hypothesize on the route of dissemination, fish guts 
isolates were collected and screened for the presence of ISCRs. For this particular 
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purpose Liza aurata species was chosen based on its feeding behaviour, which is 
characterized by a regular contact with the sediment being often extensive to the 
whole water column.  
 
7.2 Results and Discussion 
7.2.1 Screening of ISCR in bacteria collected from fish guts  
 
It has been recognized that MDR commensal bacteria inhabiting animals gut are 
an important source of bacteria causing opportunistic infections. Also, these 
bacteria can act as reservoirs of antibiotic resistance gene being a source to 
spread bacteria infecting humans (Hawkey and Jones 2009). Based on this 
hypothesis, 100 Gram-negative isolates were recovered from guts of fish 
belonging to L. aurata species. Five animals were captured in each of three 
different sampling points, according to different sources and levels of 
contamination. The three sampling sites were located in the estuary Ria de Aveiro, 
a clean sampling point, used as reference site for environmental studies by other 
authors (Nogueira et al. 2010), a sampling point contaminated with waste from a 
slaughterhouse and a third sampling point contaminated with heavy metals, 
namely mercury (Figure 39). The isolates were recovered as described in Material 
and Methods section 2.1. 
Hybridization experiments were conducted in order to evaluate the occurrence of 
insertion sequence common regions, namely ISCR1 and ISCR2, among the 
population under study. Colony blot was employed to detect the presence of 
ISCRs using the methodology described in Material and Methods sections 2.7.1 
and 2.7.3. An environmental origin for several antibiotic resistance genes as been 
hypothesized, for instance the CTX-M genes from Kluyvera genera (Rodriguez et 
al. 2004). Nevertheless in this study and among the population under study was 
not detected the presence of ISCRs. These results can be explained either due to 
the fact that a small number of animals was analysed or to the low pressure in 
these sampling points, to select for structures such ISCRs. Toleman and co-
workers hypothesize on the transfer of ISCRs from the environment to the hospital 
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settings (Toleman and Walsh 2008). Moreover, other reports show the presence of 
ISCRs in isolates collected from companion animals or food, therefore the 
boundaries of genes transfer are becoming narrower (Ma et al. 2009). Meunier 
and colleagues detected the occurrence of ISCR2 in E. coli isolates collected from 
diseased animals from France (Meunier et al. ). Also, the occurrence of resistance 
genes, such as bla and sul genes, among isolates collected from wild animals has 
been described in Portugal (Costa et al. 2006; Poeta et al. 2009). In isolates 
collected within the hospital environment, those genes are often found associated 
with the ISCRs. Therefore it might be suggested that this association is likely to be 
found also in isolates collected from wild animals. 
 
 
 
 
 
Figure 34 – Geographic location of sites where the fish included in this studied were captured. 
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7.2.2 Screening of ISCR in bacteria collected from water samples 
 
In surface water, it is difficult to find an area where antibiotics cannot be detected, 
except for the pristine site in the mountains before the rivers or streams going 
through urban or agricultural areas (Hawkey and Jones 2009). One hundred E. 
coli isolates collected from water lakes around Cardiff, Wales (United Kingdom) 
were screened for the presence of ISCRs. Colony blot was employed to detect the 
presence of ISCRs using the methodology described in Material and Methods 
sections 2.7.1 and 2.7.3. However, it was not detected the presence of ISCRs 
among these isolates. Gram-negative bacteria, where a wide range of 
mechanisms of resistance is encoded by a plethora of genes, many of which are 
highly mobile, may pose substantial problems (Hawkey and Jones 2009). 
Therefore, 750 Gram-negative isolates were collected from the water column in 
three sampling sites in the estuary Ria de Aveiro, which presented different levels 
and sources of contamination, namely: Costa Nova, Cais do Chegado and Cais do 
Sporting. Subsequently, the same methodology was employed to screen for the 
ISCR1 and 2 elements. The presence of ISCRs was not detected. Nonetheless, 
water constitutes not only a way of dissemination of antibiotic resistant organisms 
among human and animal populations, as drinking water is produced from surface 
water, but it is also the route through which resistance genes are introduced in 
natural bacterial ecosystems. In such systems, nonpathogenic bacteria could 
serve as a reservoir of resistance genes and platforms (Baquero et al. 2008b). The 
results obtained suggest that ISCRs may be rare in the environments studied. 
However, given the global panorama of dispersion of the mobile genetic elements, 
one can predict that it is a matter of time to find these structures within these 
environments. Nevertheless ISCRs free locations should be preserved and efforts 
should be put in surveillance studies for those genetic elements as well as other 
resistance genes. Despite the fact that no evidence was found of the occurrence 
of ISCRs among these isolates, it is likely that they will become present in a few 
years, facilitating the movement of resistance determinants. 
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7.2.3 General Conclusion 
 
Based on the results obtained, the geographically separated environments did not 
seem to be a biased factor for the occurrence of ISCRs. Moreover, ISCR could not 
be detected in isolates collected from the selected sampling points. 
It was not possible to hypothesize on the route of dissemination of the ISCRs 
since their presence could not be detected in the isolates collected from the fish 
guts. However, this type of study should be considered preliminary and should be 
repeated including a larger number of animals as well as different species. 
 
 
 
 
 
   141 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. General Discussion  
______________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  General Discussion 
  143 
 
8.1 ISCRs 
 
The occurrence and the genetic context of ISCR elements in clinical and 
environmental isolates were investigated during this study. ISCRs are responsible 
for the mobilization of antibiotic resistance genes, including the blaCTX-M genes, 
from any location, by a rolling-circle transposition mechanism, allowing genetic 
rearrangements by homologous recombination into a class 1 integron (Toleman et 
al. 2006a) 
The genes encoding quinolone resistance (qnr genes) are typical examples of 
complex integrons in which ISCRs have played a major role in bringing together 
antibiotic resistance genes combinations, including fluoroquinolone and extended-
spectrum β-lactam resistance genes, on single conjugative plasmids. 
ISCR1 is always found as part of a complex class 1 integron (Toleman et al. 
2006a) and this feature was fully investigated in this study.  
In K. pneumoniae and C. freundii isolates the genetic context of these structures 
was well characterized revealing that in both cases it was associated with class 1 
integron and with a qnrA gene. Since the first description of the “common regions” 
in the early 1990s, several reports worldwide describe this association, highlighting 
the success in their dissemination as well as in the movement of antibiotic 
resistance genes among different species. (Garnier et al. 2006; Quiroga et al. 
2007; Su et al. 2008).  
In contrast, ISCR2 has never been found associated with class 1 integrons. ISCR2 
is intimately associated with antimicrobial resistance genes especially 
sulphonamide resistance (sul2) and it has been found located on a number of 
plasmids adjacent to chloramphenicol/florphenicol resistance gene, floR, and sul2 
gene (Toleman et al. 2007a). However, in the Portuguese A. baumannii isolates 
was found to be chromosomally located, despite the fact that the isolates carried 
large plasmids. Nonetheless, the study of the genetic context of this ISCR2 
element revealed that it was associated with the sul2 gene reinforcing the 
association between ISCR and the sulphonamide resistance. The comparative 
study revealed that in the Argentinean isolates, ISCR2 was found to be associated 
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with the floR gene and therefore in a different genetic context than that from the 
Portuguese population. A possible explanation for that association is the fact that 
florphenicol it is widely used in the veterinary medicine in Latin America, specially 
in Brasil and Argentina. In these countries meat exportation has a major impact in 
the economy, which may be reflected in the over-use of antibiotics and ultimately 
into the emergence of resistance. The association of resistance genes, such as 
floR, to structures that can provide their dissemination among bacteria ensuring its 
“survival”, is just a matter of time. In Europe, florphenicol was licensed for the 
control of bacterial respiratory tract infections in cattle and pigs in 1995 and 2000, 
respectively, and is active against chloramphenicol resistant isolates (Blickwede 
and Schwarz 2004). Therefore, it is possible that the selection of this particular 
association still unnoticed. 
 
 
8.2 Class 1 integrons  
 
Class 1 integrons containing ISCR elements are known as complex class 1 
integrons. They contain the classic integron structure and a second copy of the 
3'CS. Between the two copies of the 3'CS is a 2.1 kb ISCR, that has been 
identified in In6, In7, In117, In34, In35, In37 and In601 followed by a variable 
region that contains resistance genes, e.g. dfrA10, catII, blaDHA-1
 (pSAL-1), blaCTX-
M-9 or blaCTX-M-2, (Su et al. 2008). In the present study, complex class 1 integrons 
were found mainly in K. pneumoniae and C. freundii isolates, for instance, the In37 
which has been previously described in countries such as China and Argentina 
(Quiroga et al. 2007). 
The gene cassettes arrays found were already described elsewhere either in 
different species or different backgrounds demonstrating the dissemination of 
these structures worldwide and between species. Additionally, a linkage between 
integron carriage and the resistance exhibited by the isolates to some antibiotics 
such as aminoglycosides, trimethoprim and β-lactams can be established. In all 
the species studied and also in the gene arrays found aadA and dfr variants were 
predominant. 
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Although nowadays streptomycin and spectomycin antibiotics are rarely used in 
patients clinical treatment, aadA gene cassette variants remain prevalent in a high 
number of arrays among Gram-negative species. White and colleagues (2001) 
reported that might suggest that these genes are not easily excised from the 
variable region. Also, an antibiotic may no longer be frequently used in therapy, 
but this does not necessarily mean that gene(s) coding for its resistance are going 
to be lost. However, several studies have shown that the exposure to a new 
antibiotic leads to a repositioning of the gene cassettes by the integrase. The 
closest gene to the promoter will be the more efficiently expressed (Collis and Hall 
1995). As resistance genes can persist within elements such as integrons, the 
association of the latter with ISCR elements exponentially potetiates their 
dissemination. Surveillance studies of this association are crucial, especially within 
the hospital environment, since the association of these two elements can pose a 
major risk for the patients by contributing for therapeutic failure. 
 
 
8.3 β-lactamase genes content 
 
The clinical implications of β-lactamases carriage, especially ESBLs, are 
numerous and can compromise patient’s treatment. Thus, rapid detection of 
ESBL-producing strains is essential to the implementation of the appropriate 
therapy and to monitor the development of resistance (Paterson and Bonomo 
2005). In the present study, different types of β-lactamases enzymes were 
detected, namely narrow-spectrum β-lactamases, ESBLs, carbapenemases and 
broad range β-lactamases. Narrow-spectrum β-lactamases, represented by blaTEM, 
were the most prevalent genes found. PCR and subsequent nucleotide sequence 
analysis performed in the clinical isolates, identified blaTEM-1 in virtually all species 
with the exception of A. baumannii. As expected, blaTEM-1 was the predominant bla 
gene among the isolates. blaTEM-1/2 have been shown to be widely disseminated 
among Gram - negative bacilli and are the main resistance mechanism to narrow 
spectrum cephalosporins (Schmitt et al. 2007). Moreover, carbapenemases 
represented by oxacilinases hydrolyzing carbapenems, namely blaoxa-40 were only 
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detected in some A. baumannii isolates. In contrast, ESBLs were detected in all 
the species and in a high percentage. This fact has been frequently observed in 
the recent years by several authors and it represents a serious concern since 
ESBLs inactivate the majority of the β-lactams frequently used such as penicillins 
and first to third generation cephalosporins (Poirel et al. 2008). Among the ESBLs 
detected blaCTX-M genes were the most frequently found and with a higher 
incidence in E. coli isolates. Interestingly those genes were not detected in K. 
pneumoniae strains resistant to third generation cephalosporins, where their 
hidrolysing activity was replaced by the presence of broad range β-lactamases, 
namely blaDHA-1. blaCTX-M are usually plasmid located and have a preferential 
hydrolytic activity against third generation cephalosporins (Eckert et al. 2006). The 
rapid dissemination of blaCTX-M worldwide and among different species is a major 
threat to clinical efficacy of third generation cephalosporins treatment (Munday et 
al. 2004). β-lactamases encoding genes are usually associated with insertion 
sequences (ISs), specially in Enterobacteriaceae and P. aeruginosa strains. In 
2003, the association of a particular insertion sequence, ISEcp1, with the blaCTX-M-
15 was reported and it has been identified in several Enterobacteriaceae isolates 
(Poirel et al. 2003). Subsequently, several studies confirmed the presence of this 
element upstream of the blaCTX-M gene. In the present study, blaCTX-M-15 when 
present was always associated with the insertion sequence ISEcp1, reinforcing the 
linkage between these two structures.  
Overall, the results of this study show that, as expected given the high selective 
pressure of the clinical environments, the emergence and prevalence of β-
lactamases is high and appears to be disseminated among different nosocomial 
species that become MDR and are able to cause severe infections. Thus, 
surveillance studies either in MDR bacteria or bacteria exhibiting low level 
resistance are of utmost importance. The information provided constitutes the 
basis of epidemiological data and may contribute to the implementation of new 
measures within the hospital environment.  
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8.4 qnr genes 
 
Different transferable qnr genes have been described so far, where qnrA, qnrB 
and qnrS appear to be the most common variants (Jacoby et al. 2008). In the 
present study, only qnrA and qnrB genes were detected, and both were found in 
K. pneumoniae and C. freundii isolates. qnrS was not detected among the isolates 
screened which leads to suggest that the former variants are dominant in our 
hospital. In both K. pneumoniae and C. freundii, qnrA genes were found 
associated with ISCR1, that is located on a plasmid and embedded in a complex 
sul1-type integron. qnrB variants were not associated with neither the orf1005 
gene nor the ISCR1 recombinase gene. Nonetheless, hybridisation experiments 
revealed that two K. pneumoniae and the C. freundii CIT1 harboured qnrA and 
qnrB genes simultaneously and both of them were located on large plasmids. 
Attempts to transfer by conjugation, the qnr genes located on those plasmids were 
unsuccessful in both K. pneumoniae and C. freundii. Moreover, isolates from both 
species carried those qnr genes on plasmids with similar sizes suggesting that the 
size of the plasmid may be the limiting condition of this transfer in vitro. 
Interestingly, plasmids with similar sizes harbouring both qnrA and qnrB genes 
simultaneously, were found in both K. pneumoniae and C. freundii, collected in the 
same hospital. Based on these findings it may be suggested that in the laboratory 
it might be difficult to accurately reproduce the appropriate conditions to the 
horizontal gene transfer in vitro. However, that does not necessarily mean that 
within the hospital environment and under favorable conditions, the gene transfer 
does not occur. Although clinical implications of the qnr genes are still unclear, it is 
accepted that these are responsible for low-level resistance to fluoroquinolone 
resistance (Yang et al. 2009). Thus the spread of such resistance determinants is 
concerning, since it may play a significant role in the emergence of resistant 
mutants and consequently therapeutic failure. Moreover, the epidemiology of 
complex sul1-type integrons, as well as the association of qnr genes to ISCR1 in 
the bacterial population analysed highlights the need for surveillance that helps to 
predict the prevalence of these mechanisms.   
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8.5 Environmental screening  
 
Antibiotic resistant organisms enter into water environments from human and 
animal sources (Baquero et al. 2008a). Evidence of the role played by wild 
animals, wastewaters and estuarine reservoirs in antibiotic resistance 
maintenance and dissemination has been provided by several reports (Costa et al. 
2006; Henriques et al. 2008; Moura et al. ; Moura et al. 2007). Bacteria found in 
these environments are able to spread their genes into water-indigenous 
microorganisms, which may in turn contain other resistance genes. The resistance 
is maintained by many antibiotics from industrial origin that circulate in water 
environments, potentially altering microbial ecosystems (Baquero et al. 2008a). A 
policy for preventing mixing human-originated and animal-originated bacteria with 
environmental organisms seems advisable, but difficult to implement. 
Despite the fact that ISCRs could not be detected in the environmental bacteria 
analysed in the present study, regardless the origin of the isolates, should not rush 
us to conclude that these are not present in these environments. Other authors 
report the presence of resistance genes, often found associated with ISCR, in the 
same sampling points (Henriques et al. 2006; Henriques et al. 2008; Moura et al. 
2007) therefore one can suggest that a wider screen would probably give positive 
results.  
 
 
8.6 Conclusions 
 
The results that are included in this thesis are of utmost importance, since they 
constitute the first study carried out in a Portuguese hospital providing therefore a 
realistic panorama of the dissemination of the ISCR elements within this highly 
selective environment. Additionally, this study also helped to highlight the 
importance of the association and implication of these elements in the 
dissemination of antibiotic resistance genes within hospital environment.  
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Thus, the following major conclusions can be withdrawn: 
 
 
1) A biased occurrence of ISCRs in environments where the antibiotic pressure is 
stronger, namely the hospital environment is observed. 
 
2) The screening of mobile genetic elements such as ISCR elements and Tn5090 
transposons in the clinical isolates showed a high occurrence of those elements, in 
different genetic contexts and associated with different antibiotic resistance genes.   
 
3) In the A. baumannii isolates the association of the ISCR2 with the sul2 gene 
does not have a strong impact in the resistance profile of these bacteria. However, 
in E. coli, K. pneumoniae and C. freundii ISCR1 was found associated with 
complex class 1 integrons, that harboured different antibiotic resistance genes 
encoding resistance to different classes of antibiotics. Since these genes are 
located in mobile elements it may therefore enhance their dissemination. 
 
4) Since ISCR were found intrinsically linked to antibiotic resistance genes and can 
mobilize the transfer these resistance determinants, a continuous surveillance of 
these elements is crucial to ensure successful treatments. 
 
5) The results obtained in this study highlight that precautions should be taken to 
prevent the dissemination of these resistance determinants within the hospital 
environment. The occurrence of MDR populations within this biased environment 
requires the implementation of simple measures (such as reduction of beds per 
ward) that combined with periodic surveillance control, will certainly contribute to 
avoid the dissemination of these bacteria among hospitalized patients.  
 
6) Although ISCR elements could not detected in isolates collected in the natural 
environment, wither surveillance studies should be performed. These studies 
would be essential, specially in areas close to the hospital discharges, 
aquacultures and domestic effluents. 
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